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ABSTRACT 
DNA damage response (DDR) is a cellular network that comprises signaling from 
DNA lesions, including DNA double-strand breaks (DSBs), and their repair. ATM and 
ATR belong to the Phosphatidylinositol-3 kinase-related kinases (PIKK) family and 
are known as the master controllers of DDR signaling. It is generally accepted that 
ATM is activated by DSBs or chromatin modifications, while ATR operates in DNA 
replication and in response to DSBs becomes activated by single-stranded DNA 
regions at the DSB ends generated by DNA end resection. DNA-PK catalytic subunit 
(DNA-PKcs), a third member of the PIKK family, is an essential component of the 
classical non-homologous end joining (c-NHEJ) pathway of DSB repair. However, the 
catalytic function of DNA-PKcs in c-NHEJ has been extensively studied, while its role 
in DNA damage signaling still remains obscure. 
In this thesis, we provide evidence of a contribution of DNA-PKcs in the checkpoint 
response as well, particularly in cells irradiated in S and G2 phases of the cell cycle. 
The role of DNA-PKcs in this process appears to be specific as this effect is not 
observed with depletion of KU70/80, an essential factor for recruitment of DNA-PKcs 
at DSBs. Analysis of G2 arrest and evaluation of the mitotic index using H3pS10 
assay after exposure of cells to IR revealed that deficiency of DNA-PKcs or its 
chemical inactivation is linked with persistent G2 checkpoint; in cells irradiated in S 
phase this hyper-activated checkpoint is entirely dependent on ATR, while in cells 
sustaining DNA damage in G2 phase it relies on both ATM/ATR. 
The requirement of ATR for the prolonged G2 checkpoint in DNA-PKcs deficient 
background suggests extensive resection at DSB ends which could be visualized by 
immunostaining of RPA. Hence, the data demonstrate that DNA-PKcs may also 
contribute to DNA damage response via regulation of DNA end resection. 
Evaluation of the effects of ATM and ATR kinases on the G2 checkpoint and DNA 
end resection by using small molecule inhibitors point to a model where ATM, ATR 
and DNA-PKcs may work as a kinase module to effectively control the G2 checkpoint 
and the process of resection after exposure to ionizing radiation. 
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1. INTRODUCTION 
1.1. DNA damage induction by ionizing radiation 
The genomes of eukaryotic cells are continuously threatened by natural background 
irradiation, such as cosmic rays and decay of radioactive isotopes in terrestrial 
environment. The use of diagnostic medical imaging, radiation therapy and nuclear 
accidents provide another source of artificial background irradiation. 
Important feature of ionizing radiation (IR) is the localized release of large amounts of 
energy that is sufficient to eject orbital electrons from atoms and molecules, thereby 
ionizing them. The energy deposition per ionizing event is about 33 eV, which is 
enough to break a strong chemical bond (1). The direct action of IR refers to the 
absorption of energy directly by the target molecule and is characteristic for 
radiations with high linear energy transfer (LET) such as neutron or α-particles. In this 
thesis IR was generated artificially using X-rays. As a sparsely ionizing form of 
radiation (low LET), X-rays are predominantly causing cellular damage indirectly by 
interacting with other atoms or molecules in the cell, mainly water, as it represents 
80% of cellular content. The resulted free radicals are very unstable, because they 
carry an unpaired orbital electron in their outer shell, and react quickly with the target 
molecules. The chemical changes from the breakage of bonds in the molecules lead 
to biological effects (1). 
As a carrier of genetic information, nuclear DNA is the most critical target of IR where 
the formation of DNA double-strand breaks (DSBs) represents the most deleterious 
lesion with high probability to convert in heritable mutations or lethal events. 
Importantly, DSBs are also naturally occurring intermediates during programmed 
biological processes like V(D)J recombination and class switch recombination (CSR) 
that are required for the adaptive immune system (2). Recently, DSB formation as a 
physiological event has been reported to occur upon stimulation of neuronal activity 
(3). 
In a healthy cell, the severe effect of IR-induced DSBs and their misrepair have to be 
avoided in order to preserve genomic stability and, in extreme cases, to suppress 
cancer development (4, 5). However, IR as a DNA damaging agent is frequently 
used in cancer therapy to induce mitotic and less frequently apoptotic cell death in 
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tumor cells (6). Since tumor cells are actively dividing and therefore probably more 
radiosensitive that resting cells (G0), the cell cycle phase (described below) is of 
great importance for radiotherapy (7). 
As shown in Figure 1, exposure of cells to IR results in many types of DSBs, whose 
presence in the cell has to be detected. Sensor proteins that can detect each type of 
DSB (if any) remain undefined. 
 
 
Figure 1: Different types of DSBs. (A) DSB with a 5’- phosphate and a 3’-OH group 
generated by restriction endonucleases, (B) IR-induced DSB with common 
3’-phosphoglycolate and a 5’-OH at the ends, (C) Clustered lesions induced by clustered 
ionization events, where a DSB contains additional forms of DNA damage, (D) Indirect DSB 
converted from an initial single-stranded break (SSB) by enzymatic processing of opposing 
base damage, (E) Indirect DSB induced after temperature-sensitive chemical processing of 
sugar lesions opposite to a SSB, (F) Clustered DSBs that can affect chromatin stability by 
nucleosome loss or deletion of larger chromatin segments. Figure obtained from Schipler 
and Iliakis, 2013 (8). 
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Much is known about the sensor molecules that detect not the type of DSB but their 
conversion in common intermediates, for example, DNA discontinuity detected by 
KU70/80 and single-stranded DNA that becomes recognized by Replication Protein A 
(RPA). Such intermediates activate an intricate DNA repair machinery that is 
supported by signaling networks termed checkpoints. The checkpoint pathways 
interact with the cell-cycle control system by halting progression through G1, S or G2 
phase, and thus provide time for faithful repair or prevent cell proliferation of 
potentially mutated cells. 
1.2. Cell-cycle control system 
Cell cycle progression requires high degree of synchronization among numerous 
enzymes to ensure faithful transfer of the genetic information over generations (9). 
The duplication of the genome requires correct order of events carried out by the cell-
cycle control system. As a result, the initiation of each stage is dependent on the 
completion of the previous one (10). Before entering cell division, the cell requires 
metabolism and intake of nutrients, as well as duplication of its genome. This takes 
place in the interphase, which is the period between one M phase and the next 
(Figure 2). Cell division includes DNA replication occurring in S phase (S indicating 
synthesis), where each chromosome must be duplicated only once per cell cycle and 
with extreme precision to prevent development of heritable genetic aberrations in the 
daughter cell. Entry into mitosis is dependent on the completion of DNA replication 
(9). 
The cell cycle contains two gap phases; the first gap (G1) is before DNA replication 
and is the first phase within the interphase; it is known as growth phase, where the 
cell conducts all its metabolic activities and grows in size. The duration of G1 phase 
varies among species and under unfavorable extracellular conditions like reduced 
growth factors signaling, cells usually enter the non-dividing G0 state. Non-
proliferating and differentiated cells remain in G0 for long periods of time without 
resuming the cell cycle. Stem cells, in contrast, have the capacity to reenter the cell 
cycle and divide (9). 
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Figure 2: The cell-cycle control. Proper progression through the cell-cycle is ensured by 
three main checkpoints. Entry into S phase by overcoming the Restriction point 
(G1/S checkpoint) is driven by G1/S- and S-phase CDK-cyclin complexes. The different types 
of DNA replication checkpoint functioning throughout the S phase are not shown in the 
figure. Before onset of mitosis, which is triggered by M-phase CDK-cyclin complexes, cells 
undergo G2/M checkpoint. In the end, the spindle checkpoint guarantees the precise 
separation of the duplicated chromosomes and therewith the metaphase-to-anaphase 
transition associated with destruction of cyclins (9). The arrows indicate the expression of the 
corresponding cyclins and activation of different CDK-cyclin complexes. 
 
The second gap (G2) occurs after DNA synthesis and is characterized by rapid cell 
growth and protein synthesis (11). The G2 phase also provides additional time for the 
cell to correct replication errors during S phase. Hence, the major purpose of the gap 
phases in the cell cycle is to assist DNA replication and mitosis by monitoring 
whether the environmental conditions are suitable for entering the next phase. Some 
cells, particularly the early embryo of the frog Xenopus laevis, do not require gap 
phases in their cell cycle to prepare themselves for mitosis (9, 12). 
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In comparison to other cell cycle phases, the M phase is relatively short and is 
considered to be composed of nuclear division (mitosis), where the duplicated 
chromosomes are segregated and divided into daughter nuclei and cell division 
(cytokinesis) that allows distribution of cytoplasmic components into two individual 
daughter cells. In this way, each daughter cell obtains a complete and identical copy 
of the genome (9). 
Key regulators of the cell-cycle control system are the cyclin-dependent kinases 
(CDKs). CDKs are a family of enzymes that phosphorylate their protein substrates at 
serine/threonine residues. Cellular CDK levels remain constant but their activities 
oscillate as the cells progress through the cell cycle. CDKs are primarily regulated by 
different types of regulatory subunits called cyclins. This leads to formation of 
different CDK-cyclin complexes throughout the cell cycle (13, 14). Furthermore, 
CDKs can be activated by phosphorylation at a conserved threonine residue by CDK-
activating kinase (CAK). In higher eukaryotes, the main candidate for CAK is the 
CDK7/Cyclin H/ménage-à-trois 1 (MAT1) complex (13, 15, 16). Inactivation of CDK-
complexes involves ubiquitin-dependent proteolysis of cyclins, removing inhibitory 
phosphates from CDK active sites by CDC25 phosphatases or inhibitory tyrosine 
phosphorylation of CDK1 by Wee1 kinase. CDK-cyclin complexes can be also 
inactivated by inhibitory subunits like p21 and p27 (13, 17).  
Proper progression through the cell cycle is governed by control mechanisms called 
cell-cycle checkpoints (10, 18). In G1 checkpoint, when the conditions for cell 
proliferation are optimal, the S-phase CDK-cyclin complexes are activated, which 
then promote entry into S-phase by overcoming the restriction point. The second 
major checkpoint which allows entry into M phase is the G2/M checkpoint, also known 
as DNA damage checkpoint. The G2 checkpoint response prevents cells to enter 
mitosis with unfaithfully repaired DNA or incomplete DNA synthesis. The third major 
checkpoint is the spindle assembly checkpoint (SAC) in metaphase, which ensures 
proper mitosis and cytokinesis. Additionally, precise replication of the genome is 
ensured by different types of DNA replication checkpoint functioning throughout the S 
phase (19). In this thesis, the focus is placed on G2 checkpoint regulation after DNA 
damage induction by ionizing radiation. 
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As sentinels for cell cycle progression, the cell cycle checkpoints regulate genome 
stability and their dysfunction may lead to cell death, increased susceptibility to DNA 
damaging agents and carcinogenesis (20). 
1.3. Mammalian DNA damage checkpoint-control after exposure to IR 
Cellular DNA damage induction by ionizing radiation activates essential checkpoint 
networks that halt progression through G1 and G2 phases of the cell cycle and slow 
down DNA synthesis. This favors restoration of DNA integrity by the repair 
mechanisms and thus protects against mutations, chromosomal aberrations and 
predisposition to cancer (21, 22). 
DNA damage checkpoints are biochemical signaling pathways that sense various 
types of sequence alterations in the DNA. Checkpoint activation requires sensors of 
DNA damage, transducers and effectors (Figure 3). Transducer kinases amplify the 
damage signal from the sensor proteins by phosphorylating other kinases or 
downstream target proteins (effectors). At the effector level the DNA damage 
checkpoint connects with the cell-cycle control machinery (22). 
The most well characterized DNA damage sensors are MRE11-RAD50-NBS1 (MRN) 
complex, KU70/80 heterodimer and poly(ADP-ribose)-Polymerase 1 (PARP1) (23). 
Candidates for such sensor molecules are also the PCNA-like proteins RAD1, RAD9 
and HUS1, which were shown to form a DNA damage-responsive complex, and the 
RFC-like protein RAD17 (21, 24, 25). The breast cancer protein BRCA1 has also 
been linked to DNA damage sensing as a part of a large BRCA1-associated genome 
surveillance (BASC) complex together with ATM, MRN, Bloom’s helicase (BLM) and 
mismatch proteins (MSH2/6 and MLH2) (26). 
ATM and ATR serine/threonine kinases, both belonging to the phosphatidylinositol-3 
kinase-related (PIKK) family, are the key signaling factors involved in DNA damage 
response (DDR) (27, 28). ATM and ATR share sequence similarities and many 
phosphorylation substrates. ATM gene product is mutated in patients suffering from 
Ataxia telangiectasia (AT), a rare autosomal recessive disease characterized by 
immune deficiency, neurodegeneration and cancer predisposition (29). Cells lacking 
ATM show a slow DNA synthesis and a defective DNA damage response (30).  
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Figure 3: Mammalian DNA damage response pathways leading to cell cycle arrest. 
ATM and ATR kinases, both members of the PIKK family, are key components of the DNA 
damage signaling. In response to ionizing radiation ATM is activated by DSBs or changes in 
chromatin structure, while ATR responds to single-stranded DNA regions generated at DSB 
ends; therefore ATR is considered to have secondary function with reference to ATM in 
checkpoint development. Once activated, ATM and ATR phosphorylate many downstream 
targets that collectively promote cell-cycle arrest. See text for details. Figure obrained from 
Löbrich and Jeggo, 2007 (31). 
 
ATR was shown to be essential for cell survival (32-34) and has been linked with 
Seckel syndrome which is associated with impaired DNA damage response and 
genomic instability (35, 36). The prevailing view is that in response to IR, ATM is 
recruited primarily by DSBs or changes in chromatin structure through MRN complex 
(37, 38) and is thought to have central role in activating DNA damage checkpoints 
leading to cell cycle arrest (39). In contrast, ATR is believed to function in perturbed 
DNA replication, and its activation by DSBs requires ATR-interacting protein (ATRIP), 
9-1-1 complex (RAD9-HUS1-RAD1), TOPBP1, Claspin and the generation of ssDNA 
regions at DSB ends coated with RPA complexes, a process known as DNA end 
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resection (27, 40-44). Therefore, ATR is considered to have a secondary function 
with reference to ATM in checkpoint development and regulation (45, 46). Later on, 
the signal is amplified by mediator proteins like MDC1, 53BP1, MRN and BRCA1 and 
forwarded to the downstream effector kinases CHK1 and CHK2. 
Two ATM-dependent G1 checkpoints networks have been described. The fast 
response includes rapid phosphorylation of CHK2 by ATM leading to subsequent 
phosphorylation of CDC25A phosphatase, which in turn promotes proteolysis of 
CDC25A and therewith prevents activating dephosphorylation of CDK2 at Thr14 and 
Tyr15 (31). This fast branch of the G1 arrest represents the DNA-damage sensing 
mechanism and may delay DNA synthesis. The second component of G1/S 
checkpoint is slower since it utilizes transcriptional activation by the tumor suppressor 
p53 and protein synthesis of the CDK-inhibitor p21. Since p53 is involved in 
regulation of apoptosis and genomic integrity (47, 48), this aspect of the G1/S 
checkpoint may be important for eliminating cells sustaining DNA-damage by 
apoptosis. 
In S phase, collapsed or stalled replication forks activate ATR leading to 
phosphorylation of CHK1 and the subsequent degradation of CDC25A phosphatase. 
In this way the inhibitory phosphates masking the active site of CDK2 cannot be 
removed and inhibition of CDK2-Cyclin A/E complexes halts the entry into G2 phase. 
This checkpoint response in S phase, also known as intra-S phase checkpoint, 
prevents firing of new replication origins and therewith slows down DNA replication. 
DSBs in G2 phase can directly activate ATM which leads to subsequent activation of 
CHK2. This in turn promotes phosphorylation of CDC25C at Ser216 to block its 
function. A parallel pathway in G2 checkpoint is initiated by indirect activation of ATR 
via DSB end resection and subsequent phosphorylation of the checkpoint kinase 
CHK1. Phosphorylation of CDC25C phosphatase by CHK1 prevents removal of 
inhibitory phosphorylation of CDK1, which is essential for initiating mitosis (31, 49). 
In addition, the DNA damage response involves regulation of CDK1-cyclinB complex 
activity by regulating the mRNA levels of cyclin B and its translocation from the 
cytoplasm during S and G2 phases to the nucleus at the beginning of mitosis (50-52). 
Evidence also suggests the involvement of Never-in-mitosis A related protein 
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kinase 1 (NEK1) in checkpoint signaling, which was shown to function early in DNA 
damage checkpoint control independently of ATM and ATR signaling pathways (53, 
54). 
In summary, the widely held view is that the central players in DNA damage-induced 
checkpoints are ATM and ATR kinases, which initiate a phosphorylation signaling-
cascade to transmit the damage signal. This results in inhibition of CDK-cyclin 
complexes and ensures cell cycle arrest. This delay in cell cycle progression does 
not only provide time for repair in the cell cycle phase where lesions are induced. 
Moreover, the DNA damage checkpoint ensures initial processing of the lesion and 
its safe transition into a cell cycle phase where repair can proceed optimally (22). 
Therefore, the next section reviews DSB repair pathways and their dependence on 
cell cycle phase and checkpoint response. 
1.4. Eukaryotic DSB repair pathways and their dependence on cell cycle 
phase and checkpoints 
Two main repair pathways are capable of processing and rejoining DSBs and thus 
eliminating their adverse consequences – non-homologous end joining (NHEJ) and 
homologous recombination repair (HRR). 
The classical or canonical NHEJ (c-NHEJ) is a fast process successfully eliminating 
DSBs within 10-30 minutes that simply rejoins DNA ends without necessarily 
restoring the original sequence around the break (Figure 4). Therefore, it is also 
considered as error-prone repair pathway. The essential feature of c-NHEJ is 
DNA-dependent protein kinase (DNA-PK) comprising KU70/80 heterodimer and an 
evolutionary new catalytic subunit DNA-PKcs (cs indicating catalytic subunit). 
Synapses of two DNA-PK complexes at the two broken ends provides a platform for 
repair by recruiting XRCC4/XLF/DNA ligase IV complex (55). Other factors that 
contribute to DSB end processing include, 53BP1, H2AX, Artemis, polynucleotide 
kinase (PNK), and DNA polymerases λ and µ (56). Nevertheless, evidence suggests 
that XRCC4 and XLF could act as a complex also in the early step of end joining and 
independently of Ligase IV where the filamentous structure of XRCC4-XLF may hold 
the DSB ends together (57-59). Recently, a paralog of XRCC4 and XLF, named 
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PAXX, was identified as a novel component of NHEJ machinery whose interaction 
with KU promotes end joining (60, 61). 
C-NHEJ is not solely involved in repairing DSBs induced by IR; along with RAG-1 
and RAG-2 (recombination-activating genes), the enzymes of NHEJ have been 
shown to be essential for V(D)J recombination, where DSBs are natural events. This 
process occurs in lymphocytes and involves the rearrangement of variable (V), 
diversity (D) and joining (J) segments on ‘cut-and-paste’ basis. This leads to a 
diverse repertoire of immunoglobulins and T-cell receptors (62). C-NHEJ is also 
required for class switch recombination (CSR) in B cells,  a process that allows the 
change of antibody class from immunoglobulin M (IgM) to IgA/E/G (63). 
 
Figure 4: Schematic overview of classical 
non-homologous end joining (c-NHEJ). 
Crucial component of c-NHEJ is the 
enzymatically active DNA-PK complex, 
composed of a large catalytic subunit, termed 
DNA-PKcs, and DNA-binding factor 
KU70/KU80. As a heterodimer, KU70 and 
KU80 form a basket-shaped structure which 
enables the complex to slide along dsDNA 
with KU70 located proximal and KU80 distal to 
the end. The recruitment of DNA-PKcs guides 
KU70/80 to move inwards. After being 
processed, the ends are sealed by 
Ligase IV/XRCC4/XLF complex.  The 
indicated phosphorylation events represent 
the post-translational modifications of DNA-PK 
complex, which result in dissociation of 
DNA-PKcs from the ends. Removal of 
KU70/80 is possibly due to ubiquitination (64). 
Figure adapted from Dueva and Iliakis, 2013 
(65). 
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Although c-NHEJ is considered as error-prone repair pathway as it is associated with 
sequence alterations around the break, due to its high speed c-NHEJ is more 
efficient in suppressing translocations when compared to other alternative forms of 
end-joining operating with slower kinetics (described below) (65). Besides its high 
speed, Simsek and Jasin have further demonstrated that translocation formation is 
suppressed by the XRCC4/Ligase IV component of c-NHEJ (66). Therefore, c-NHEJ 
is considered a caretaker of genomic integrity and suppressor of tumor development 
(67, 68). C-NHEJ operates throughout the cell cycle and was shown to be 
independent of checkpoint response (69, 70). 
In comparison to c-NHEJ, HRR is a slow process but accurate in restoring the 
original sequence in the vicinity of the break since it requires a homologous template 
or a sister chromatid (Figure 5). As a consequence, HRR is limited to S and G2 
phases of the cell cycle. Critical step in HRR is homology search and strand invasion 
in the donor DNA, which requires 3’ single-stranded DNA (ssDNA) overhangs. The 
latter are produced by the combined action of DNA exonucleases and helicases 
which remove terminal nucleotides from the 5’ ends, a process known as DNA end 
resection (71, 72). MRN complex promotes initial processing of broken DNA ends 
(73). Essential role for this short-range resection (50-100 nt) have CtBP-interacting 
protein (CtIP), and the tumor suppressor protein BRCA1 while the long-range 
resection (several thousand nt) is continued by Exonuclease 1 (EXO1), DNA2 
helicase/nuclease and the Bloom helicase (BLM) (74-79). Hence, the MRN complex 
has two important roles in DDR – in checkpoint activation by recruiting ATM and in 
HRR initiation by promoting nucleolytic resection of DSB ends. The resulting long 
3’ ssDNA overhangs on both sides of the break are rapidly coated by RPA 
heterotrimer composed of RPA70, RPA32 and RPA14 subunits, where the binding 
size of one RPA molecule is ~30 nt (80, 81). Thereby, RPA stabilizes the ssDNA by 
preventing formation of secondary structures and protects it from nucleolytic 
cleavage. Notably, RPA-covered ssDNA serves as a platform for recruiting ATRIP 
and initiating ATR-CHK1 checkpoint signaling pathway and the 32-kDa subunit of 
RPA is a target of ATM, ATR and DNA-PKcs. In the following step, recombination 
mediators such as RAD52, RAD51 paralogs and the tumor suppressor BRCA2 assist 
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the displacement of RPA by RAD51 recombinase leading to the formation of RAD51-
ssDNA nucleoprotein filament.  
         
Figure 5: Schematic overview of homologous recombination repair (HRR). HRR relies 
on the formation of ssDNA-RPA intermediates generated by nucleolytic degradation of 
terminal nuleotides. Displacement of RPA by RAD51 recombinase ensures strand invasion 
with the template DNA sequence and homology search. Detailed description in text. Figure 
adapted from Dueva and Iliakis, 2013 (65). 
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The subsequent homology search and strand invasion into the template DNA 
sequence result in D-loop formation, where a polymerase starts synthesizing the 
complementary strand of ssDNA. The 3’-overhangs participate in the formation of 
Holliday junctions which in the last step of HRR become resolved resulting in 
restoration of the original sequence around the break with or without crossover (71). 
In addition to these standard repair processes, mounting evidence supports the role 
of a third pathway in cells of higher eukaryotes considered to be an alternative form 
of end joining (a-EJ) that is independent of KU70/80 and DNA-PKcs (Figure 6) (82-
85). It operates with slower repair kinetics than c-NHEJ and profits from 
microhomologies around the DNA ends, especially when the ends are processed by 
nucleases and end resection is initiated. This alternative form of end joining is 
considered as a backup non-homologous end joining (B-NHEJ) pathway, which 
becomes engaged at the DSB when either c-NHEJ or HRR fail to process the ends 
(65, 86). Throughout this thesis, the term a-EJ will be used to refer to this repair 
pathway. 
 
Figure 6: Alternative pathways of end joining (a-EJ) are considered highly inaccurate of 
restoring the original DNA sequence. See text for details. Figure adapted from Dueva and 
Iliakis, 2013 (65). 
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A-EJ has been characterized to be more error-prone than c-NHEJ with higher 
probability of deletions, sequence alterations around the break as well as with higher 
risk of translocation formation. Therefore, a-EJ is considered an ultimate source of 
genomic instability. Proteins implicated in a-EJ are Histone H1, PARP1, MRN, CtIP, 
as well as DNA ligase III or DNA ligase I that are involved in the rejoining step (87-
90). A-EJ has been shown to operate in all cell cycle phases but is functionally 
enhanced in S and G2 (91-93). Interestingly, data from our laboratory have shown 
that a-EJ is compromised in non-cycling (plateau phase) cells (94). 
In conclusion, the error-prone NHEJ is predominantly used to preserve DNA integrity 
in higher eukaryotes throughout the cell cycle. In G2 phase, however, HR additionally 
ensures DSBs repair in an error-free manner. The process of end resection is a 
crucial step during HR and once initiated, NHEJ factors cannot bind the ends and the 
DSB is committed to be repaired by HR. Therefore, the next chapter will focus on the 
factors coordinating initial processing of DNA ends. 
1.5. Regulation of damage-induced DNA-end resection 
Extensive processing of DNA ends by exonucleases leads to the formation of 
ssDNA-RPA intermediates that initiate ATR-dependent checkpoint signaling and 
engage homologous recombination to seal the break in S and G2 phase. As the 
resected DNA ends could not be repaired by c-NHEJ and possibly the extended DNA 
end resection suppress a-EJ (95), it is intuitive to speculate that  DNA end resection 
could be a critical step in repair pathway choice (96, 97). Moreover, the regulation of 
DNA end resection initiation is another important parameter of the repair pathway 
selection, which is controlled by a number of proteins (Figure 7) and requires 
extensive modifications of chromatin structure (98). 
KU70/80 heterodimer, the DNA-binding component of DNA-PK complex, has 
extremely high affinity for dsDNA and is believed to be the first protein that binds 
directly the DSB ends. The subsequent recruitment of DNA-PKcs primes the DSB 
ends for direct ligation by classical NHEJ (85). 
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Figure 7: Regulation of DSB end resection and its impact on DNA damage response. 
Resection, the formation of ssDNA, at DNA ends occurs as an intermediate structure during 
DNA repair and replication. ATM stimulates the nucleolytic processing of DSBs, where MRN 
complex has a crucial function of recruiting and activating ATM. In response to DNA damage, 
histone variant H2AX becomes phosphorylated at Ser139 (termed γH2AX) by ATM. γH2AX, 
MDC1 and ATM form a positive feedback loop, where MDC1 binds γH2AX and further 
expands the DNA damage signals. 53BP1 has a protective role on DSB ends from resection 
and therefore promotes repair by c-NHEJ in G1 phase. BRCA1 triggers HRR and suppresses 
53BP1-dependent c-NHEJ in G2 phase. The ssDNA regions, covered by RPA, serve as a 
substrate for checkpoint activation via ATR-Chk1 pathway. The hierarchical recruitment of 
resection factors is represented as precisely as possible. See text for details. 
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In comparison with KU70/80, MRN complex also has high affinity for DSB ends, and 
although KU70/80 seems to be the main opposing factor against mobilization of MRN 
to damaged chromatin (99), unpublished data from our laboratory suggest that KU 
and MRN possibly interact to fine-tune and control the fate of DSB. 
In undamaged cells ATM exists as an inactive dimer which is rapidly activated upon 
DNA damage-induction by auto-phosphorylation at Ser1981. This modification 
induces dissociation of the inactive ATM dimer into active ATM monomers (100). 
MRN complex has an essential function in stimulation of ATM kinase activity by 
enhancing the stable binding between ATM and its substrates (101, 102). MRN 
consists of MRE11 (nuclease component), RAD50 (ATPase activity) and the 
Nijmegen breakage syndrome factor NBS1/Nibrin (Xrs2 in yeast). NBS1 has yet 
unknown enzymatic activity but is responsible for the nuclear localization of RAD50 
and MRE11 (103). The retention of MRN to damaged chromatin is mediated through 
phospho-dependent interaction between NBS1 and Mediator of DNA damage 
checkpoint 1 (MDC1) (104). 
In response to DNA damage, a phosphorylation of the histone variant H2AX at 
Serine 139 results in the formation of γH2AX, which has a significant role in the 
recruitment of DNA-damage-response proteins NBS1, 53BP1 and BRCA1 (105-107). 
Although H2AX gene is not essential for cell survival, H2AX deficiency is associated 
with increased radiosensitivity and pronounced repair defects (106). H2AX is 
primarily phosphorylated by ATM (108), where phosphorylated H2AX initiates 
recruitment of MDC1 and MRN complex to further amplify and propagate the DNA 
damage signal by recruitment of more ATM molecules, thus creating a positive 
feedback loop (107, 109-111). Phosphorylated MDC1 also promotes accumulation of 
the E3 ubiquitin ligase RNF8 to the DSB, which in turn ubiquitylates histone H2A and 
enables the recruitment of 53BP1 and BRCA1 (112). 
RAD17 is a replication checkpoint clamp-loader that promotes ATR activation. 
Recently, Wang and colleagues have shown that RAD17 stimulates also ATM 
activation and DNA end resection by recruiting MRN complex to DSBs. RAD17 
depletion is associated with impaired phosphorylation of ATM as well as of its 
substrates CHK2, NBS1, and γH2AX (25). 
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Sartori et al. first reported about the role of human CtIP in end resection, where it 
functionally interacts with MRN to promote HR (74). CtIP exhibits endonuclease 
activity with specificity for 5’ flaps which is essential for cell survival in response to IR 
and topoisomerase poisons (113). Work by Sartori and colleagues demonstrated that 
the peptidyl-prolyl cis/trans isomerase 1 (PIN1) is involved in the regulation of DSB 
resection where PIN1 controls the stability of CtIP and its degradation (114). 
Recently, tetramerization of CtIP was shown to be required for proper DNA-end 
resection during homologous recombination (115). Another intriguing study by 
Jackson and colleagues provided evidence that the protein lysine deacetylase SIRT6 
promotes end resection by deacetylation of CtIP. RNAi-mediated depletion of SIRT6 
effectively reduces RPA foci number after camptothecin (CPT) treatment without 
affecting γH2AX foci formation (116). 
CtIP was shown to associate with BRCA1 in late S and G2 phases of the cell cycle, 
where CtIP-BRCA1 interaction depends on CDK-mediated phosphorylation of CtIP at 
Ser327 (79, 117). As an E3 ubiquitin ligase, BRCA1 also promotes ubiquitination of 
CtIP at multiple lysine residues without leading to its degradation, but by enhancing 
CtIP binding to chromatin after DNA damage-induction (118). A high-resolution assay 
to measure the extent of resection in eukaryotes, established by Huertas and 
colleagues, revealed that BRCA1 modulates the speed of CtIP-mediated resection, 
although the BRCA1-CtIP interaction is not essential for this process. Thus, under 
normal conditions BRCA1 increases the rate of end resection while abrogation of 
CtIP-BRCA1 interaction by CtIP-Ser327 mutation leads to shorter resected tracks 
(119). 
MDC1 was identified to control the formation of damage-induced 53BP1, BRCA1 and 
NBS1 foci formation. 53BP1 and MDC1 are placed upstream of ATM, where both 
proteins activate ATM through independent pathways (120-122). A breakthrough 
study by Nussenzweig and colleagues demonstrated that 53BP1 inhibits resection in 
BRCA1-deficient cells. Thus, in S phase BRCA1 downregulates NHEJ and allows 
end resection by promoting removal of 53BP1. The authors proposed that 53BP1 
and BRCA1 directly regulate repair pathway choice (123). In the same way, absence 
of 53BP1 is associated with ATM-dependent increase of end resection that favors the 
involvement of a-EJ pathways during class switch recombination (124). The 
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suppressive function of 53BP1 on end resection in G1 is assisted by RIF1, where 
RIF1 recruitment relies on ATM-dependent 53BP1 phosphorylation (125-128). The 
ubiquitin-binding protein RAP80 was reported to recruit BRCA1 to DNA damage 
sites, implicating the involvement of ubiquitin-dependent signaling pathway in DDR 
(129-131). In a model proposed by Jeggo and colleagues, 53BP1, RAP80 and 
ubiquitin chains serve as a barrier for the process of resection and therefore promote 
NHEJ. However, in G2 phase, BRCA1 is assisted by the de-ubiquitylating enzyme 
POH1 to fully remove 53BP1 from the break. The data suggest that BRCA1 alone is 
not sufficient for full clearance of 53BP1 (132). Once nucleolytic cleavage by MRN-
CtIP-BRCA1 complex is initiated and RPA binds ssDNA, EXO1, DNA2 and the BLM 
helicase are recruited to facilitate extensive resection. Simultaneously, the 32-kDa 
subunit of RPA undergoes extensive phosphorylation by ATM, ATR and DNA-PK. 
RPA-ssDNA structures promote HRR and serve as a platform for ATR-mediated 
checkpoint signaling by recruiting the ATR activator ATRIP, the adapter proteins 
TOPBP1 and Claspin, and the checkpoint clamp 9-1-1 (133, 134). Therefore, ATR 
activation is considered to be mediated through ATM-dependent resection and 
contributes to checkpoint maintenance. 
In summary, initiation of end resection is decisive for the repair pathway that will 
rejoin the DSB and influences the DNA damage response.  
It appears that the catalytic subunit of DNA-PK does not fit into checkpoint control 
and regulation of DNA end resection owing to its key role in c-NHEJ. However, 
accumulating data generate evidence about a dual role of DNA-PKcs on c-NHEJ and 
HR (135-138) but the exact mechanism by which DNA-PKcs regulates HR is still 
unclear. Since this is not the only exception regarding non-canonical roles of 
DNA-PKcs, besides its necessity in c-NHEJ, the following section will review the role 
of this kinase in the DNA damage response and beyond. 
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1.6. The role of DNA-PK holoenzyme in DSB repair and beyond 
1.6.1. The DNA-PK complex in DSB repair and its regulation 
The first indication about a DNA-activated protein kinase in human cells was reported 
in 1985 by Anderson and colleagues, where they present evidence about dsDNA-
dependent phosphorylation of multiple proteins in eukaryotic cells including the heat 
shock protein HSP90 (139). Now we know that DNA-dependent protein kinase (DNA-
PK) is composed of a large catalytic subunit (DNA-PKcs,  ~460 kDa, gene name 
PRKDC), and a dsDNA-binding component KU70/80 heterodimer (140). Originally, 
DNA-PKcs was termed p350 (indicating a ~350 kDa ATP-binding polypeptide) (141).  
Due to its size, the crystal structure of DNA-PKcs at 6.6 Å resolution was resolved 25 
years later, in 2010 (142). Despite the low resolution, the position of all known 
domains in a 3D model is now resolved (Figure 8). KU70/80 is a highly abundant 
protein complex initially identified as an autoimmune antigen. KU70/80 binds with 
high affinity dsDNA in a sequence independent manner and loads DNA-PKcs onto 
DNA (140, 143). The resulting association of KU70/80 with DNA-PKcs leads to the 
assembly of an enzymatically active complex with preference to phosphorylate 
SQ/TQ sequences (64, 143). 
DNA-PKcs alone has a weak kinase activity in the presence of dsDNA, but the 
presence of KU70/80 increases its kinase activity 5-10 fold and also stabilizes the 
formation of the DNA-PKcs-KU-DNA complex (64). In vitro experiments with highly 
purified DNA-PKcs and KU70/80 revealed that under low salt conditions DNA-PKcs 
is able to bind dsDNA ends in the absence of KU70/80, while under higher salt 
conditions activation of DNA-PKcs is dependent on KU70/80 (144). Once activated, 
DNA-PK phosphorylates itself as well as other factors involved in NHEJ apparatus 
such as both KU subunits and XRCC4 (143). 
DNA-PKcs belongs to the PIKK family together with ATM, ATR, mammalian target of 
rapamycin (mTOR), suppressor of morphogenesis in genitalia (SMG1) and 
transformation/transcription domain-associated protein (TRRAP) (145).  Despite the 
sequence similarities to the PI3K family of kinases, PIKK family members are not 
lipid kinases and are referred as atypical protein kinases (146, 147). 
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Figure 8: The structure of DNA-PK catalytic subunit: front (left) and side (right) view of 
the molecule. The many α-helical HEAT repeats (helix-turn-helix motifs), indicated with 
green, contribute to the formation of a ring structure. The head/crown region contains the 
C-terminal region that carries the FAT and FATC domains (magenta) and the kinase domain 
(yellow). Through the putative DNA-binding domain (cyan) DNA-PKcs may bind directly to 
DNA and become active independently of KU subunits. Figure obtained from Sibanda et al. 
2010, Nature (142). 
 
Unlike ATM and ATR, a clear DNA-PKcs homolog has not been identified in the 
genome of lower eukaryotes such as Saccharomyces cerevisiae. Interestingly, both 
KU70 and KU80 were shown to be present in distantly related organisms (from yeast 
to human) (148). However, rodents have much lower levels of both DNA-PKcs and 
KU than primate cells. The correlation between DNA-PK levels and species’ life-span 
suggests that the evolutionary breakthrough of DNA-PKcs is a mechanism to 
enhance genomic stability (143). 
Being involved in V(D)J recombination, loss of DNA-PKcs function leads to defective 
DSB repair and V(D)J recombination, and, thus, to hypersensitivity to IR and 
nonfunctional immune system. (149-153). This phenotype, defined as severe 
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combined immunodeficiency (SCID), has also been described in KU80-deficient mice 
(154, 155). 
As already outlined above, free dsDNA ends and the DNA-binding factor KU70/80 
represent the primary activators of DNA-PKcs. Another important mechanism of 
DNA-PK regulation is through posttranslational modifications. It has been reported 
that extensive auto-phosphorylation of DNA-PKcs results in inhibition of its kinase 
activity and release of DNA-PKcs from the breaks (156). Two major auto-
phosphorylation site clusters, ABCDE and PQR, have been analyzed, while the 
phosphorylation sites L and M as well as N and JK clusters still remain undefined 
(Figure 9) (56, 138, 157). There are reports consistent with the model of activating 
DNA-PKcs by intra-molecular (cis) auto-phosphorylation, as well as in trans by the 
synapsed opposing complex (158-161). As a highly dynamic molecule, a 
conformational change at its N-terminus may also regulate its kinase activity 
independently of DNA or KU70/80 (162). Additionally, dissociation of DNA-PKcs from 
the complex with DNA is also stimulated through phosphorylation of DNA-PKcs by 
c-Abl tyrosine kinase. The binding of c-Abl to the KU association site at the carboxy-
terminal domain of DNA-PKcs reveals antagonistic functions of KU and c-Abl toward 
DNA-PK activity (163, 164). 
 
 
Figure 9: Domains within DNA-PK catalytic subunit. Auto-phosphorylation sites are 
shown in red. LRR indicates the leucin-rich region. FAT domain is called after the three 
kinases sharing the domain FRAP/mTOR, ATM and TRRAP. PI3K and PRD designate PI3 
kinase domain and PI3K regulatory domain, respectively. FAT-C specifies the FAT domain at 
the extreme C-terminus. Figure obtained from Lieber, 2010 (56). 
DNA-PKcs is also an in vivo substrate of other PIKK kinases like ATM and ATR as 
reported by several studies (135, 165, 166). Another post-translational event that 
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stimulates DNA-PKcs activity in vitro is the association of Poly-adenosine 
diphosphate (ADP)-ribose by PARP-1, which seems to be independent of KU70/80 
(167). 
In addition to the post-translational modifications, it has been reported that DNA-PK 
activity can also be regulated through protein-protein interactions. An example in this 
regard is the human KU80 Autoantigen Related Protein-1 (KARP-1) gene product, 
which is expressed from the KU80 locus through an upstream promoter and 
additional exons. This 9-kDa extended derivative of KU80 was reported to modulate 
DNA-PK activity (168, 169). 
1.6.2. DNA-PKcs in the DNA damage checkpoint 
DNA-PKcs is considered as a crucial component of c-NHEJ pathway, which is 
independent of checkpoint activation. Therefore, the role of DNA-PKcs in checkpoint 
signaling has been discounted. Nevertheless, DNA-PKcs has been shown to 
phosphorylate proteins involved in checkpoint signaling pathways. 
A model was proposed, where DNA-PK together with ATM and ATR modulate p53 
activity via phosphorylation of its N-terminus, which results in disruption of 
MDM2/p53 interaction and subsequent stabilization of p53 (143). This links DNA-PK 
to the regulation of G1 checkpoint. 
As briefly mentioned above, the 32-kDa subunit of the ssDNA-binding RPA is a target 
of ATM, ATR and DNA-PK, where Ser4 and Ser8 residues have been described to 
be DNA-PK-specific (170, 171). RPA-coated ssDNA intermediates during HRR 
activate ATR and therewith the G2 checkpoint. In a proposed mechanism by Serrano 
et al. phosphorylation of RPA32 by DNA-PKcs and p53 by ATM and ATR leads to 
dissociation of p53-RPA complex and promotion of HR (172). 
Since DNA-PKcs phosphorylates several substrates involved in checkpoint 
activation, an early study from 1997 proposed that the IR-induced cell cycle arrest in 
human cells lacking DNA-PK activity is abrogated. On the contrary, the DNA-PKcs-
deficient cell line M059J not only did show proper G2/M cell cycle arrest but also 
twenty-four hours after irradiation the fraction of G2/M cells was significantly higher 
when compared to the DNA-PK-proficient cell line M059K (173). It has been 
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concluded that DNA-PKcs is not required for the activation of G2 checkpoint and 
although DNA-PKcs phosphorylates DNA damage sensing molecules, other kinases 
may compensate for its absence (173). 
Similar to G2-checkpoint activation, our laboratory showed that DNA-PKcs is required 
for the recovery of IR-induced S-phase checkpoint as measured by total DNA 
synthesis. This effect seems to be DNA-PKcs specific and independent of c-NHEJ 
abrogation since other c-NHEJ components examined, Ligase IV, XRCC4 and KU80, 
failed to establish the phenotype observed in DNA-PKcs deficient cells (174). 
Similarly, Oakley and colleagues reported that DNA-PKcs defect is associated with 
impaired replication checkpoint and that DNA-PKcs contributes to CHK1 activation in 
response to hydroxyurea, CPT or etoposide treatment (175). The phosphorylation of 
RPA32 at Ser4/Ser8 by DNA-PKcs seems to be of great importance for the 
regulation of replication stress checkpoint activation (171). 
Interestingly, a study by Tomimatsu et al. implicated DNA-PKcs in activating DNA 
damage response in ATM-deficient cells by phosphorylating DDR proteins involved in 
chromatin remodeling like KRAB-associated protein 1 (KAP-1) (176). 
Hence, DNA-PK catalytic subunit appears to be important contributor to the recovery 
of IR-induced S- and G2-checkpoints and its exact role in DNA damage signaling 
remains to be defined. 
1.6.3. Other functions of DNA-PK in the cell 
The kinase activity of DNA-PK has been extensively studied by virtue of its 
requirement for NHEJ and V(D)J recombination in mammalian cells (150, 177, 178). 
Nevertheless, accumulating data reveal damage-independent functions of DNA-PK, 
such as transcriptional modulation, viral infection, telomere protection and mitosis. 
DNA-PKcs was originally found as a kinase that phosphorylates transcription factor 
Sp1 upon binding to GC-rich promoter sequences (179). Another study reported a 
regulatory role of DNA-PK on RNA polymerase II, which catalyzes DNA transcription 
(180). DNA-PKcs/KU70/KU80 complex, together with Topoisomerase IIβ, is also 
recruited to active transcription units (181). A more recent study implicates 
DNA-PKcs as a transcription modulator in prostate cancer progression (182). Other 
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data also implies a role for DNA-PKcs in mitosis which might be independently of KU 
and DNA damage (183-185). 
DNA-PKcs was reported previously to suppress infection of cells with Herpes simplex 
virus by inhibiting viral replication (186, 187). Recently, DNA-PK activity has been 
implicated in HIV-1-induced CD4 lymphocyte death, which leads to 
immunodeficiency (188). 
DNA-PKcs is also required for maintenance of the chromosome ends (telomeres) 
(189-191). If left unprotected, telomeres can be recognized as DSBs and their ‘repair’ 
may result in chromosome fusions that may lead to genomic instability. 
All these findings define DNA-PKcs as a multifunctional kinase regulating many 
aspects of cellular physiology. This thesis focuses on the less-defined role of DNA-
PKcs in DNA damage signaling, particularly G2 checkpoint activation after ionizing 
radiation. 
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2. AIMS OF THE THESIS 
DNA-PKcs is an evolutionally new DNA repair enzyme functioning as an alignment 
protein for broken DNA ends. DNA-PKcs is an abundant protein, as it represents up 
to 1% of total soluble protein from HeLa nuclei (192). The presence of DNA-PKcs in 
eukaryotic genomes shifts the predominant repair pathway for DSBs from HRR in 
yeast to NHEJ in primates, i.e. with increasing genome size genome integrity 
becomes more crucial than error-free repair. Since DNA-PKcs requires the KU70/80 
heterodimer to be recruited to the break, one may ask why the cell has developed 
such a big protein (460 kDa) with auto-phosphorylation capacity, which is not capable 
to recognize a DNA break. The many phosphorylation sites of DNA-PKcs may lead to 
a series of conformational changes of the molecule and therewith to multiple 
functions in the cell beyond DSB repair. 
As a central component of c-NHEJ, the contribution of DNA-PKcs to DNA double-
strand repair is well characterized. DNA-PKcs’ role in signaling and checkpoint 
response has been discounted and therefore requires in depth studies. Recent 
experiments from our laboratory provide evidence for a role of DNA-PKcs in 
checkpoint response, particularly for cells irradiated during S and G2 phase of the cell 
cycle. The aim of this study is to contribute to this effort by investigating how DNA-
PKcs contributes to checkpoint activation and development. Additionally, the role of 
the master signaling kinases ATM and ATR and a possible cross-talk between 
ATM/ATR and DNA-PKcs has been scrutinized. 
To study the contribution of DNA-PKcs in checkpoint response the M059J cell line is 
commonly used, which fails to express the catalytic subunit of DNA-PK and is 
radiosensitive (193). Its paired and control counterpart cell line, which was isolated 
from the same tumor specimen, M059K, is relatively radioresistant, contains a 
functional catalytic subunit and expresses normal levels of DNA-PK activity (194). 
Asynchronously growing cells exposed to IR activate DNA damage checkpoints, 
which result in cell cycle delay. The resulting abnormal cell cycle distribution is easily 
analyzed by measuring the DNA content of individual cells by fluorescence-activated 
cell sorting (FACS). Increase of the G2 fraction of cells reflects activation of the G2 
checkpoint and cell cycle arrest in G2 phase. The associated delayed mitosis can be 
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studied more precisely by the combined staining of DNA and mitotic marker proteins 
such as phosphorylated histone H3 at Ser10 that allows estimation of the mitotic 
index (MI). Furthermore, we sought to expand previously published G2 arrest 
analyses (173) by using different doses of IR and multiple time-point intervals after 
irradiation. 
In regard to the requirement of end resection for activating DNA damage checkpoint 
in G2 phase, accumulation of RPA in the vicinity of the break was visualized as 
discrete foci by immunofluorescence (IF) and served as a marker for ongoing 
resection. With reference to G2 checkpoint, the kinetics of RPA foci formation is 
studied in G2 phase cells selected by appropriate staining. In an effort to unveil the 
contribution of each component of DNA-PK holoenzyme to the end resection 
process, we applied RNA interference (RNAi) to reduce the gene expression of 
KU70/80, combined with a specific inhibitor of DNA-PKcs. 
The outcome of these experiments should clarify the role of DNA-PKcs on DNA 
damage response. 
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3. MATERIALS AND METHODS 
3.1. Materials 
3.1.1. Major laboratory apparatuses 
Laboratory apparatus Model Provider 
Cell and Particle Counter 
Z2 Coulter 
Counter® 
Beckman Coulter Inc., USA 
Cell culture CO2 incubators  MCO-18AC(UV) Sanyo, Japan 
Centrifuge MultifugeTM 3S-R Heraeus, Germany 
Centrifuge (tabletop) Biofuge FrescoTM Heraeus, Germany 
Confocal laser scanning 
microscope 
TCS SP5 Leica Microsystems, Germany 
Electroporation device NucleofectorTM I 
Lonza Cologne GmbH, 
Germany 
Flow cytometer  GalliosTM Beckman Coulter Inc., USA 
Laminar flow cabinet HERAsafeTM Heraeus, Germany 
Imaging scanner Typhoon 9400 GE Healthcare, USA 
Infrared imaging system Odyssey® LI-COR Biosciences, Germany 
Inverted phase contrast 
microscope  
Motic AE31 Motic, China 
NanoDropTM 
spectrophotometer 
ND-1000 Thermo Scientific, Germany 
pH meter InoLab® WTW GmbH, Germany 
SDS-PAGE equipment  Bio-Rad, USA 
UV/VIS  Spectrophotometer UV-2401PC Shimadzu, Japan 
Wet transfer system  Bio-Rad, USA 
X-ray machine, Isovolt 320 
HS 
 
General Electric, 
Pantak/Seifert 
 
3.1.2. Cell lines 
Name Characteristics Cell type Growth media 
Human cell lines 
82-6 hTERT wt fibroblast MEM + 1% NEAA 
M059K repair-proficient malignant glioblastoma DMEM 
M059J DNA-PKcs deficient malignant glioblastoma DMEM 
Mouse cell lines 
Exo1 wt Exo1 proficient mouse fibroblasts DMEM 
Exo1-/- Exo1 knock-out mouse fibroblasts DMEM 
 _________________________________________________________________ MATERIALS AND METHODS 
 
29 
 
3.1.3. Plasmids 
Name Characteristics Provider 
GFP expression vector pEGFP-N1 vector Clontech 
 
3.1.4. Antibodies for immunofluorescence microscopy 
Name Specificity Host / Type Dilution Provider 
Primary antibodies 
Cyclin B1 (H433) Human Rabbit polyclonal 1/150 Santa Cruz 
RPA70 
Human, 
mouse 
Mouse 
monoclonal 
1/300 
Kenny et al., 
1990 (195) 
Secondary antibodies 
AlexaFluor®488  Mouse IgG Goat polyclonal 1/400 Invitrogen 
AlexaFluor®568 Rabbit IgG Goat polyclonal 1/400 Invitrogen 
 
3.1.5. Antibodies for western blot 
Name Specificity Host / Type Dilution Provider 
Primary antibodies 
KU70 (529) Human 
Mouse 
monoclonal 
1/4.000 GeneTex 
KU86 (H-300) Human, mouse, rat Rabbit polyclonal 1/5.000 Santa Cruz 
CtIP (D76F7) Human 
Rabbit 
monoclonal 
1/1.000 Cell Signaling 
MRE11 Human, mouse, rat Rabbit polyclonal 1/5.000 
Novus 
Biologicals 
NBS1 Human, mouse Rabbit polyclonal 1/1.000 
Novus 
Biologicals 
GAPDH Human, mouse, rat 
Mouse 
monoclonal 
1/10.000 
Merck 
Millipore 
α-Tubulin 
(AA13) 
Human, mouse, rat 
Mouse 
monoclonal 
1/10.000 Sigma-Aldrich 
Secondary antibodies 
IRDye® 
680LT 
Mouse IgG Goat polyclonal 1/10.000 LI-COR Biosc. 
IRDye® 
680LT 
Rabbit IgG Goat polyclonal 1/10.000 LI-COR Biosc. 
IRDye® 
800CW 
Mouse IgG Goat polyclonal 1/10.000 LI-COR Biosc. 
IRDye® 
800CW 
Rabbit IgG Goat polyclonal 1/10.000 LI-COR Biosc. 
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3.1.6. Antibodies for flow cytometry 
Name Specificity Host / Type Dilution Provider 
Primary antibody 
Histone H3 (pS10) Human, mouse Rabbit polyclonal 1/5000 Abcam 
Secondary antibody 
AlexaFluor®488 Rabbit IgG Goat polyclonal 1/400 Invitrogen 
 
3.1.7. Software 
Software Provider Application 
Adobe® Creative Suite® 6 Adobe Systems Inc., USA Graphic design 
EndNote® X7 Thomson Reuters, USA Reference management 
ImarisXT® 7.0 
Bitplane Scientific 
Solutions, Switzerland 
Immunofluorescence 
image analysis 
Kaluza® 1.2 for Gallios 
Beckman Coulter Inc., 
USA 
Flow cytometry analysis 
Leica Application Suite 
Advanced Fluorescence 
(LAS AF) 
Leica Microsystems, 
Germany 
Confocal microscopy  
image acquisition 
Microsoft Office® 2010 Microsoft, USA 
Word processing (Word), 
Data analysis and 
calculation (Excel) 
WinCycle AV 
Phoenix Flow Systems, 
USA 
Cell cycle analysis 
SigmaPlot® 11.0 Systat Software Inc., USA 
Graphical presentation of 
data 
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3.1.8. Chemicals 
Name        Provider  
Aluminium sulfate, Al2(SO4)3    Roth  
Ammonium persulfate (APS)     Roth  
Beta (β)-mercaptoethanol      Merck  
Bromphenol blue       Sigma-Aldrich  
Bovine serum albumin (BSA) fraction V   Roth 
Calcium nitrate, Ca(NO3)2      Roth 
CHK2i       Calbiochem 
Coomassie brilliant blue G-250     Serva 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES)      Roth 
4’,6-diamidino-2-phenylindole (DAPI)    Serva  
Dimethyl sulfoxide (DMSO)     Sigma-Aldrich 
Disodium hydrogen phosphate, Na2HPO4  Roth 
Ethanol absolute       Sigma-Aldrich  
Ethylenediaminetetraacetic acid (EDTA)  Roth 
Gelatin from cold water fish skin     Sigma-Aldrich  
Glucose        Roth  
Glycerol        Roth  
Glycine        Roth 
Hydrochloric acid, HCl     Roth 
KU55933        Calbiochem 
L-lactic acid       AppliChem 
Magnesium chloride, MgCl2     Sigma-Aldrich 
Methanol absolute       Sigma-Aldrich  
Mirin        Santa Cruz Biotechnology 
Monosodium phosphate, NaH2PO4   Roth  
Non-fat dry milk       Roth 
NU7441        Tocris Bioscience 
Paraformaldehyde (PFA)     Roth 
Phosphoric acid, H3PO4     Roth  
Potassium chloride, KCl      Roth 
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Potassium dihydrogen phosphate, KH2PO4  Roth 
Potassium hydroxide, KOH    Roth 
PromoFluor Antifade Reagent    PromoKine 
Propidium iodide (PI)     Sigma-Aldrich 
Protease inhibitor cocktail     Thermo Scientific 
RIPA buffer        Thermo Scientific  
RNasa A        Sigma-Aldrich 
Rotiphorese® Gel 30 (37,5:1), 
30% acrylamide/bis-acrylamide solution   Roth  
Sodium chloride, NaCl      Roth  
Sodium hydroxide, NaOH      Roth  
Sodium dodecyl sulfate (SDS)     Roth 
Sorbitol       Fluka 
Tetramethylethylanediamine (TEMED)    Fluka  
Tris(hydroxymethyl)aminomethane (Tris)   Roth  
Triton X-100        Roth 
Tween®-20 (polysorbate 20)     Roth 
UCN01       Calbiochem 
VE821       Haoyuan Chemexpress 
 
3.1.9. Cell culture consumables 
Name        Provider  
Dulbecco’s Modified Eagle Medium (DMEM)  Sigma-Aldrich 
Fetal bovine serum (FBS)     Gibco Life Sciences 
McCoy’s 5A (Modified) Medium    Sigma-Aldrich 
Minimum essential medium (MEM)   Sigma-Aldrich 
Non-essential amino acids (NEAA)   Merck Millipore / Biochrom 
Penicillin       Sigma-Aldrich 
Phosphate-buffered saline (PBS)    Roth 
Streptomycin      Sigma-Aldrich 
Trypsin       Biochrom 
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3.2. Methods 
3.2.1. Cell cultivation 
Cell lines were maintained at 37 °C in a humidified incubator with 5 % CO2. Cells 
were cultured as monolayers in 100 mm cell culture dishes with 15 ml of growth 
medium supplemented with 10 % fetal bovine serum (FBS), 100 μg/ml penicillin and 
100 μg/ml streptomycin. The growth medium used for 82-6 hTERT was 
supplemented additionally with 1% non-essential amino acids (NEAA). Exponentially 
growing human cells were plated into 100 mm dishes at concentrations of 
0.5-1.2x106 cells per dish and passaged every two days. Faster growing cells of 
other species were seeded in lower numbers. 
For passaging or harvesting the cells, growth media was removed, the cell 
monolayer was washed once with 1x phosphate buffered saline (PBS) and 
subsequently with 2 ml of 0,05 % Trypsin-EDTA. To let the cells detach from the 
surface, the culture dishes were incubated for 3 min at 37°C. Trypsin was then 
inactivated by adding fresh growth media and cells were resuspended to avoid cell 
aggregation. For determination of the cell number an electronic particle counter 
(Beckman Coulter) was used. 
Cells were discarded after approximately 30 passages to avoid genetic drift. After 
thawing frozen cells, the initial two passages were not used for experiments. All cells 
used in experiments were in the exponential phase of growth. Corresponding growth 
media and other supplements for cell culture are listed in 3.1.2. 
3.2.2. Cryopreservation of cells 
For long-term storage, living cells were maintained at low temperatures using the 
protocol of Borrelli et al. 1987 with dimethylsulfoxid (DMSO) as a cryoprotective 
agent (196). This freezing protocol ensures adequate recovery after thawing with no 
reduction in plating efficiency or delayed cell growth. 
After trypsinization approximately 4x106 exponentially growing cells were centrifuged 
at 4°C and the pellet was gently resuspended in 250 µl of cold freezing solution A, 
containing 5 mM KH2PO4, 25 mM KOH, 30 mM NaCl, 0.5 mM MgCl2, 20 mM L-lactic 
acid, 5 mM glucose, and 0.2 M sorbitol. Cells were further kept on ice. After addition 
 _________________________________________________________________ MATERIALS AND METHODS 
 
34 
 
of 250 µl freezing solution B, which is identical to freezing solution A but 
supplemented with 20 % DMSO, cells were mixed thoroughly and immediately frozen 
at -150°C in cryovials. 
The thawing procedure included rapid thawing of cells and their dilution in pre-
warmed (37°C) growth medium at a density of ~2 x 106 cells per 100 mm cell culture 
dish. On the day after thawing the cells, the growth media was changed to remove 
DMSO. 
3.2.3. X-ray irradiation 
Irradiation of cells was carried out at room temperature (RT) using X-ray machine 
(GE Healthcare), operated at a maximum energy of 320 kV, 10 mA with 1.65 mm 
aluminium filter. To achieve an optimal dose rate, the distance between X-ray tube 
and irradiation table was adjusted according to the cell culture vessel. Thereby, 
30-60 mm diameter cell-culture dishes and 25 cm2 flasks were irradiated at a 
distance of 50 cm, while 100 mm diameter dishes and 75 cm2 flasks were exposed to 
IR at 75 cm distance from the irradiation source. Additionally, rotation of the 
irradiation table during exposure reduced intensity fluctuations within the irradiation 
field. Different X-ray doses were applied to induce various numbers of DSBs. The 
dose rates at 50 cm and 75 cm distance were ~2.6 Gy/min and ~1.2 Gy/min, 
respectively. Controls were not exposed to irradiation. In order to avoid temperature 
fluctuations while performing H3pS10 assay, cells were irradiated on a thin-walled 
aluminium box filled with pre-warmed water. 
3.2.4. Drug treatments 
For treatments with kinase inhibitors, fresh and pre-warmed growth medium 
supplemented with each drug was added to the cells 1 hour before irradiation. Final 
concentrations of the drugs are listed below. Control cells were treated with the 
corresponding concentrations of DMSO. For the H3pS10 assay specifically, the 
growth media was not exchanged; rather the kinase inhibitors were dissolved in a 
small volume of media and distributed to each cell culture flask to reach the desired 
final concentration. After irradiation, as well as treatment with kinase inhibitors, the 
cells were returned in the incubator or in the warm-room for the specified time 
intervals. 
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All experiments for determination of mitotic index were performed in a warm-room 
located close to the irradiation source and specifically designed for highly sensitive 
assays susceptible to temperature fluctuations. 
Table 1: Used drugs 
Drug Drug description Designation 
Working 
concentration 
CHK2i Specific inhibitor of CHK2  400 nM 
KU55933 Specific inhibitor of ATM ATMi 10 µM 
Mirin Inhibits MRE11 nuclease activity  75 µM 
NU7441 Specific inhibitor of DNA-PKcs DNA-PKi 5 µM 
UCN01 Specific inhibitor of CHK1 CHK1i 100 nM 
VE821 Specific inhibitor of ATR ATRi 5 µM 
 
3.2.5. Transfection of cells with siRNA 
RNA interference (RNAi) is a conserved adaptive response where RNA molecules 
suppress post-translational gene expression by degradation of the target mRNA 
(197). As a research tool, RNAi via transfection is used to introduce double-stranded 
short interfering RNA (siRNA) molecules into cells in order to prevent gene 
expression. 
Transfection is a non-viral method that enables the introduction of any naked nucleic 
acid molecules into cultured cells. In this thesis, transfection of siRNA duplexes into 
cultured eukaryotic cells was performed using Nucleofector® Technology (Lonza). 
This electroporation-based method developed by Amaxa® applies short electric 
pulses to temporarily destabilize the cell membrane and thus make it permeable. In 
this way, siRNA oligonucleotides in the surrounding media move into the cytoplasm. 
Two days before transfection cells were seeded on 100 mm dishes. To avoid cell 
mortality and resistance to uptake macromolecules after transfection, cells were 
maintained in the log phase of growth. Cell density (confluency) at the time of 
nucleofection® was between 40-70% depending on the cell line. 
siRNA duplexes were purchased from Eurogentec (if not stated otherwise). The 
constructs consisted of ~19 base pairs with 2-base deoxynucleotide overhangs 
(Table 3). Cells were harvested by trypsinization and centrifuged at 1200 rpm for 3 
min. Up to 4 x 106 cells were resuspended in 100 μl of custom transfection buffer 
(80 mM NaCl, 5 mM KCl, 12 mM glucose, 25 mM HEPES, 40 mM 
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Na2HPO4/NaH2PO4, 20 mM MgCl2, 0.4 mM Ca(NO3)2) and 200 pmol siRNA was 
added. Cells were then quickly transferred into an Ingenio® cuvette and subjected to 
nucleofection® with the corresponding program (Table 2). The sample was 
immediately removed from the cuvette and transferred into freshly prepared pre-
warmed (37 °C) growth medium. The untreated control sample (mock-transfection) 
was comprised of cells that were not treated with siRNA but subjected to 
nucleofection® procedure. For immunofluorescence experiments, cells were directly 
plated in 30 mm dishes with glass coverslips and directly returned to the incubator. 
The transfected cells were used for experiments 48 hours after transfection. For 
western blot analysis cells were plated in 100 mm dishes and protein detection was 
performed 24 to 72 hours post transfection. Delivery efficiency of siRNA was 
confirmed using Green Fluorescent Protein (GFP) expression vector, where green 
fluorescence was measured by flow cytometry 24 hours after transfection. Thereby, 
the transfection efficiency is defined as the percentage of cells in the population 
expressing GFP protein. 
Table 2: Nucleofector® programs 
Cell line Program 
82-6 hTERT X-23 
M059K X-01 
M059J X-01 
Table 3: siRNA sequences 
Target 
mRNA 
siRNA sequence (5’→3’) Provider/Reference 
CtIP GCUAAAACAGGAACGAAUCdTdT 
Yu and Chen, 2004 (117) 
Sartori et al., 2007 (74) 
DNA2 #9: AGACAAGGUUCCAGCGCCAdTdT 
Peng et al., 2012 (198) 
DNA2 #11: AAGCACAGGUGUACCGAAAdTdT 
EXO1 CAAGCCUAUUCUCGUAUUUdTdT Gravel et al. 2008, (199) 
EXO1  #1 
FlexiTube GeneSolution 
siRNA (Product no. 
1027416), Qiagen 
EXO1  #2 
EXO1 #7 
EXO1 #8 
KU70 GAGUGAAGAUGAGUUGACAdTdT Britton et al., 2013 (200) 
MRE11 GGAGGUACGUCGUUUCAGAdTdT 
Yuan and Chen, 2010 
(201) 
NBS1 #1:UAACCUUGUUGGCCUGAAGUAGAUG 
Shiotani et al., 2013 (202) 
NBS1 #2: CCAACUAAAUUGCCAAGUAUU 
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3.2.6. Flow cytometry analyses 
3.2.6.1. Cell cycle analysis by flow cytometry 
Flow cytometry analysis of cell suspensions stained with fluorescent dyes that bind to 
DNA enables the measurement of DNA content of individual cells. Propidium iodide 
(PI) has a red fluorescence and can be excited with an Argon laser (488 nm). PI 
stains all double-stranded nucleic acids; therefore the PI solution contains RNAase 
which clears away all dsRNA so that the bound PI reflects only the amount of DNA. 
Prior to cell cycle analysis, cells were harvested, fixed in pre-chilled 70 % ethanol 
and stored at least over night at 4°C. Cells were then spun down, ethanol was 
aspirated and the cell pellet was resuspended in PI staining solution. After 15 min-
incubation at 37°C in a water bath, cells were subjected for measurement of the DNA 
content on a Beckman Coulter Gallios® flow cytometer with a 620 nm bandpass filter. 
PI solution was not removed during measurement, where 10.000-20.000 events per 
condition were analyzed. Proper gating based on forward and side scattering was 
ensured to detect the cells of interest. Cell cycle analysis was performed using 
WinCycleTM software. 
3.2.6.2. Bivariate flow cytometry 
The histogram obtained with PI staining does not show the cells in mitosis (M), which 
have the same DNA content as cells in G2 phase. Therefore, two-parameter 
(bivariate) flow cytometry was used for simultaneous analysis of DNA content and 
phospho-histone H3 (Ser10) staining as a marker of mitotic cells (203). In order to 
avoid temperature fluctuations, the cell harvesting procedure was performed with 
pre-warmed solutions in a warm-room with constant temperature of 37°C. On the day 
before the experiment, the caps of the cell culture flasks were closed to ensure 
steady state CO2 atmosphere and the flasks were relocated from the incubator to the 
warm-room. 
Cells were first washed briefly with PBS. Since mitotic cells are rounded up and can 
be easily detached mechanically from the surface, aspiration was avoided and the 
PBS solution was transferred to the 15 ml-Falcon® tube. Cells were then harvested 
by trypsinization and centrifuged for 5 min at 1200 rpm at 4°C. After fixation in pre-
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chilled 70 % ethanol, cells were stored over night at -20°C. For immunofluorescent 
staining, cells were incubated for 5 min on ice with 500 μl of cold PBS containing 
0.25 % Triton X-100 and centrifuged for 5 min at 4°C. After one-hour incubation at 
RT in 1 ml blocking buffer (PBG), the cells were stained with 100 μl of primary 
antibody (see 3.1.6) diluted in blocking buffer on a shaker for 1 h at RT. 
Subsequently, the cells were spun down for 3 min at 1200 rpm and the supernatant 
with unbound antibody was aspirated. The cell pellet was washed once with 1 ml 
PBS and stained with secondary antibody as outlined above, but in the dark for 1 h. 
Finally, the cells were washed once with PBS, stained with propidium iodide and 
subjected to analysis. Totally 20.000 cells per condition were analyzed. Further 
acquisition of H3pS10-AlexaFluor® 488 signal was achieved by gating the fraction of 
diploid cells based on DNA-PI. Compensation was not applied for this kind of 
measurement. Data analysis was performed using Kaluza 1.2 software. The mitotic 
index was determined as the fraction of cells in mitosis. 
Importantly, not more than 1 x 106 cells per sample were used for staining and 
minimum volume of PBS was used for washing, where ~50 µl of supernatant was left 
during aspiration in order to avoid losing cells after each centrifugation step. 
Table 4: Solutions for flow cytometry 
 
 
 
 
 
 
 
 
 
Name Compounds 
PBG 
0.2 % gelatin 
0.5 % BSA (fraction V) 
1x PBS pH 7,4 
Permeabilization solution 
0.25 % Triton X-100 
PBS pH 7,4 
Propidium iodide (PI) staining 
 
40 µg/ml propidium iodide 
62 µg/ml RNaseA 
 
Buffer for RNaseA, pH 7.6  
10 mM Tris 
100 mM EDTA 
50 mM NaCl 
 
Buffer for PI staining 
0.1 M Tris 
0.1 M NaCl 
5 mM  MgCl2 
0.05 % Triton X-100 
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3.2.7. Immunofluorescent staining 
For immunofluorescent detection of IR-induced foci (IRIF), cell were plated on 20 mm 
glass coverslips in 30 mm cell culture dishes and grown for two days. 82-6 hTERT 
cells were plated in a concentration of 80 000 cells per dish, while M059K and M059J 
cells were seeded in a concentration of 100 000 and 200 000 cells/dish, respectively. 
Prior to antibody staining, cells were transferred in fixative solution (PFA, 2% 
paraformaldehyde) for 15 min, washed once with PBS and then permeabilized with 
P-solution (100 mM Tris pH 7.4, 50 mM EDTA pH 8.0, 0.5 % Triton X-100) for 5 min 
at RT. Subsequently, cells were washed with PBS and blocked with phosphate-
buffered gelatin (PBG: 0.2 % gelatin, 0.5 % bovine serum albumin, PBS) overnight at 
4°C or at least 1 h at RT. For cell cycle analysis, the remaining cells were collected 
and fixed with pre-chilled 70 % ethanol. 
All antibodies used for immunofluorescent staining were diluted in PBG (see 3.1.4). 
For every coverslip 80-100 µl of antibody solution was added on a parafilm sheet. 
Coverslips were gently inverted with the cells facing down onto the drop of antibody 
solution. After incubating with primary antibodies 1.5 h at RT, cells were washed 
three times with PBS for 5 min and incubated with AlexaFluor®-conjugated secondary 
antibodies in dark for 1 h. To visualize nuclei, the cells were counterstained with 
25 ng/ml 4’,6-diamidino-2-phenylindole (DAPI) dissolved in PBS for 15-20 min at RT. 
Finally, cells were washed with PBS (3 times for 5 min) and mounted on microscopic 
slides using PromoFluor Antifade Reagent (PromoKine) diluted 1:1 with distilled 
water. After solidification of the mounting media in dark at RT, 3D-images were 
captured using confocal microscope (Leica Microsystems). 
Table 5: Solutions for immunofluorescence 
Name Abbreviation Compounds 
4’,6-diamidino-2-phenylindole DAPI 
25 ng/ml DAPI 
1x PBS pH 7,4 
Phosphate buffered gelatin 
(Blocking buffer) 
PBG 
0.2 % gelatin 
0.5 % BSA (fraction V) 
1x PBS pH 7,4 
2% paraformaldehyde PFA 2 % PFA in Milli-Q H2O 
Permeabilization solution P-Solution 
100 mM Tris pH 7,4 
50 mM EDTA 
0.5 % Triton X-100 
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3.2.8. Laser Scanning Confocal Microscopy 
One of the most important advantages of laser scanning confocal microscopy 
(LSCM) toward conventional wide-field fluorescence microscopy is optical 
sectioning – the ability to obtain high-resolution pseudo 3D-images of a thin 
specimen at multiple depths. This eliminates the need for a microtome sectioning, 
which is usually used for epifluorescence microscopy. 
The term ‘confocal’ refers to the focus of the final image which corresponds to the 
point of focus in the specimen. The elimination of out-of-focus information is obtained 
by a pinhole aperture situated in a conjugate plane in front of the detector 
(a photomultiplier, PMT) (Figure 10). 
 
Figure 10: Schematic overview of confocal microscopy. Figure obtained from ‘Laser 
Scanning Confocal Microscopy’ from Claxton, Fellers and Davidson 
The pinhole regulates the diameter of the light beam and thus filters the unfocused 
background signal for the final image. Hence, the detector can detect only light that 
has passed through the pinhole (in-focus portion of light). Since the pinhole greatly 
reduces the amount of light in the final image, increase of signal intensity is achieved 
by a laser as an excitation source and a highly-sensitive PMT for better detection of 
the emission light. In contrast to the traditional mercury arc lamp, the laser generates 
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strong monochromatic light with a specific wavelength which can excite more 
fluorophores per fraction of time.  
The laser beam in a LSCM system passing through a light source aperture is 
reflected by a dichroic mirror, recollected by an objective lens and directed to a 
fluorescently labeled specimen in a defined focal plane. The fluorescent emission 
from the specimen in the same focal plane passes back through the dichroic mirror 
and is transmitted to the PMT. Detection with PMT allows signal acquisition of one 
pixel per time. Therefore, the LSCM is equipped with motorized scanning mirrors 
(galvanometric scanner) which scan the horizontal laser beam across the specimen 
in a consecutive manner; one of the scanning mirrors moves the beam along the 
x-axis and the other in y direction. As a result, an optical section from the sample is 
generated that represents the image obtained from a single focal plane (z-section). 
Movement of the sample in the z-axis by a piezoelectric stage allows to collect series 
of multiple z-optical sections (z-stack) which then serve for digital reconstruction of 
the 3D structure by the provided software. This final image of the specimen contains 
only the in-focus information. Additionally, the use of multiple fluorescent dyes and 
lasers with different spectral characteristics (i.e. emission and excitation 
wavelengths) enables simultaneous detection of more than one target molecules 
within the same biological material. 
3.2.9. Image acquisition and foci analysis 
For IRIF analysis, immunofluorescently-stained cells were visualized with LAS AF 
software provided with the LCSM system (Leica).  
In all experiments, a scanning step of 0.5 µm along the z-axis through the whole 
nuclei was set to obtain a z-stack (~10 µm). For each sample 5 to 10 fields were 
scanned to obtain an average of 30 G2 phase cells per sample. The settings for each 
parameter are listed below. Parameters like laser intensity, PMT gain and offset 
varied between individual experiments but were kept constant within a single 
experiment. To avoid ‘spillover’ between different channels during simultaneous 
detection of multiple fluorescent dyes, each channel was scanned sequentially. 
Foci analysis was performed by Imaris® software (Bitplane). Fluorescent spots with a 
diameter above 0.5 µm within each nucleus were determined as foci. Threshold 
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values of the pattern recognition parameters were kept constant during the whole 
analysis process. For data presentation were used 2D projections of the 3D 
renderings of all image stacks. 
Table 6: Settings for image acquisition of Leica TCS-SP5 
Parameter Settings / Value 
Objective HCX PL APO lambda blue; 63.0x1.4 OIL UV 
Pinhole 95.55 µm 
Pixel size 200 nm 
Resolution 1024 x 1024 
Scan direction bidirectional 
Sequential scan between stacks 
Speed 400 Hz 
Zoom factor 1.2 
z-step size 0.5 µm 
 
Table 7: Parameters for detection of fluorescent dyes by LSCM 
Dyes Excitation Filter range 
DAPI 405 nm 410-550 nm 
AlexaFluor® 488 488 nm 495-550 nm 
AlexaFluor® 568 594 nm 575-650 nm 
 
3.2.10. Bradford protein assay 
Bradford assay is a quick and sensitive colorimetric assay for quantitative analysis of 
total protein in solution in the range of 1 – 1500 mg/ml. The assay, first described by 
Marion Bradford in 1976 (204), is based on absorbance shift of the dye Coomassie 
Brilliant Blue G-250 when bound to proteins. 
The unbound form of Coomassie (cationic) is reddish/brown and has a maximum 
absorption at 470 nm. Under acidic conditions, the dye binds to proteins, 
preferentially to basic amino acid residues (arginine, lysine and histidine), and the 
protein-bound dye becomes anionic and blue. The protein-dye complex results in a 
shift in the absorption spectrum from 470 to 595 nm, where the increase of 
absorption is proportional to the amount of bound dye, i.e. concentration of protein in 
the sample. Standard protein (BSA) in a linear concentration range from 0.1 to 
2.0 mg/ml was used for calibration. Protein concentration was determined with 
UV-Vis spectrophotometer. 
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Table 8: Bradford reagent 
Components 5x concentrate 
Coomassie Brilliant Blue G-250 0.05 % (w/v) 
Methanol / Ethanol 25 % (v/v) 
Phosphoric acid (H3PO4) 45 % (v/v) 
 
3.2.11. SDS-PAGE and immunoblotting 
Conventional immunoblotting was applied to detect proteins of interest by separating 
them according to their molecular weight. Proteins from whole cell lysates were 
prepared with radioimmunoprecipitation assay (RIPA) buffer supplied with protease 
inhibitor cocktail according to manufacturer’s instructions (Themo Scientific). 
Thereby, 1x106 trypsinized human cells were lysed with 50-100 µl of RIPA buffer. 
10-50 μg of the protein extracts were mixed 1:1 with 2x Laemmli sample buffer 
(LSB). Before loading on gels, the samples were denatured for 5 min at 96°C and 
spun down for 30 sec at 13.000 rpm. Protein extracts were resolved on 10 % sodium 
dodecyl sulfate (SDS) polyacrylamide gel with a constant voltage of 8,3 V/cm, a 
procedure termed SDS-polyacrylamide gel electrophoresis (SDS-PAGE). 
For western blotting, the separated proteins from the SDS-polyacrylamide gel were 
transferred onto an Odyssey® 0.22 µm nitrocellulose membrane (LI-COR 
Biosciences) for 1h at 100 V by using wet transfer apparatus. Temperature of 4°C 
was kept constant during the entire transfer procedure. The membrane was blocked 
with 5 % non-fat dry milk in TBS-T (0.05 % Tween®-20 in 1x PBS) for 2 hours at RT 
and thereafter incubated with primary antibodies over night at 4°C. Primary 
antibodies were diluted in 2,5 % non-fat dry milk in PBS-T (1:1 dilution of WB 
blocking buffer with PBS-T) as listed in 3.1.5. After washing 3 times (10 min each) 
with PBS-T, the membrane was incubated for 1 h at RT with secondary antibodies 
diluted in PBS-T. Prior to detection, the membrane was washed again as described 
above and let dry. For detecting the proteins of interest Odyssey® Infrared Imaging 
System (LI-COR Biosciences) was used. 
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Table 9: Solutions for SDS-PAGE and western blot wet transfer 
 
Name Abbreviation Compounds 
Solutions for SDS-PAGE 
Rotiphorese® Gel 30 (37,5:1) 
4x Stacking Gel buffer 
pH 6.8 
SGB 
0.5 M Tris-HCl 
0.4 % SDS 
4x Resolving Gel 
buffer, pH 8.8 
RGB 
1.5 M Tris-HCl 
0.4 % SDS 
1x Running buffer 
 
0.025 M Tris-HCl 
0.192 M glycine 
0.1 % SDS 
2x Laemmli sample 
loading buffer pH 6.8 
LSB 
0.065 M Tris-HCl 
0.01 M EDTA 
20 % glycerol 
3 % SDS 
0.02 % bromophenol blue 
5 % β-mercaptoethanol 
5 % Stacking gel 
 
5 %  Rotiphorese® Gel 30 
0.125 M 4x SGB 
0.1 % SDS 
0.1 % APS 
0.2 % TEMED 
10 % Resolving gel 
 
10 %  Rotiphorese® Gel 30 
0.37 M 4x RGB 
0.1 % SDS 
0.1 % APS 
0.1 % TEMED 
Sensitive Coomassie 
solution for staining of 
SDS-PAGE gels 
 
5 % aluminium sulfate 
0.02% Coomassie Brilliant Blue G250 
2 % (w/v) phosphoric acid 
10 % ethanol 
Solutions for western blot wet transfer  
4x Electrode buffer, 
pH 8.3 
 
0.1 M Tris-HCl 
0.7 M glycine 
Western blot transfer 
buffer 
WB-TB 
25% 4x Electrode buffer 
20 % methanol 
Phosphate-buffered 
saline- Tween®-20 
pH 7.6 
PBS-T 
1x PBS 
0.05 %  Tween®-20 
Blocking buffer 
 
5 % non-fat dry milk 
PBS-T 
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4. RESULTS 
Part 1: How does DNA-PKcs contribute to G2 checkpoint response? 
4.1. Persistent G2 checkpoint associated with DNA-PKcs deficiency is ATR-
dependent 
First reports discounted the involvement of DNA-PKcs in G2 phase checkpoint and 
therefore did not consider it as a DSB signaling molecule (173). Rather, DNA-PKcs is 
thought to be exclusively implicated in DSB repair by c-NHEJ, where together with 
KU70/80 heterodimer comprise the DNA-PK holoenzyme. However, previous 
experiments from our laboratory indicate a possible role for DNA-PKcs in checkpoint 
regulation in cells irradiated in S and G2 phase of the cell cycle (205). The 
contribution of DNA-PKcs to the G2 checkpoint was investigated by utilizing two 
isogenic glioblastoma cell lines M059K and M059J isolated from the same tumor 
specimen (194). M059K cell line expresses normal level of DNA-PKcs activity, while 
M059J cells lack p350, the catalytic component of DNA-PK because of a frameshift 
mutation in PRKDC (DNA-PKcs gene) (193, 206, 207). 
G2 arrest after ionizing radiation can be investigated by one-parameter flow cytometry 
analysis using propidium iodide (PI) staining. PI is a fluorescent dye that binds to 
dsDNA and thus enables the measurement of DNA content (Figure 11 A). Another 
approach to study specifically cells sustaining damage in G2 phase is the two-
parameter flow cytometry, combining PI and phospho-histone H3 (H3pS10) staining 
(Figure 11 B). Histone H3 is phosphorylated at Serine 10 during mitosis and staining 
with antibody against phospho-histone H3 ensures discrimination between G2 and 
mitotic cells, where the reduction of the mitotic index is a direct indicator of the G2 
checkpoint response (203). A corresponding confocal image of Histone H3pS10 
stained cells is shown on Figure 12. 
Exposure of actively proliferating cells to IR leads to accumulation of cells at the G2/M 
border, which resembles the increased G2 fraction on the cell cycle histogram 6 
hours after irradiation with 2Gy  (Figure 11 A). 
 ________________________________________________________________________________ RESULTS 
 
46 
 
 
Figure 11: G2 checkpoint assays. G2 checkpoint can be studied by (A) staining the DNA 
with propidium iodide (PI) and measuring the percentage of cells in G2 phase of the cell 
cycle. For a precise analysis of cell cycle distribution was used Multicycle AVTM software. 
Time frame of experiment is 0h to 24h post IR treatment. G2 checkpoint activated specifically 
in cells irradiated in G2 phase (B) can be studied by combined DNA (x axis) and 
phosphorylated Histone H3 at Ser10 (y axis) staining that allows discrimination between G2 
and mitotic cells and thus determination of the mitotic index (MI; percentage of cells in 
mitosis against total number of cells). Time frame of H3pS10 assay is 0-8 h post IR. The 
cells used as an example are actively growing 82-6 normal human fibroblasts immortalized 
with hTERT. 
 
 
Figure 12: Confocal image of mitotic cells using Histone H3 (phospho S10) staining in 
ethanol-fixed M059J cells. Secondary antibody was conjugated to Alexa Fluor® 488. Nuclei 
were counterstained with propidium iodide (PI). 
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Since the accumulation of cells in G2 phase arises through progression of cells from 
S phase, the increase of the G2 fraction above the levels of unirradiated cells 
represents primarily the cells irradiated in S phase. Irradiation of asynchronous cell 
culture also results in delayed mitosis. As shown on Figure 11 B, the percentage of 
mitotic cells (represented in the gates) is decreased 2 hours after irradiation with 1Gy 
and reaches normal levels at the 6-hour time point. 
As shown on Figure 13, exposure of cells to ionizing radiation causes a time-
dependent increase in the fraction of G2 cells. The G2 arrest is also dose-dependent, 
as the fraction of G2 cells rises with increasing doses of IR. Repair-proficient M059K 
cells irradiated with 1Gy show a slight increase of the G2 fraction at the 3-hour time 
point, while the higher fraction of G2 cells induced with 2Gy persists until 12 hours 
post IR. In both cases, the G2 fraction of cells exposed to IR reaches the level of non-
irradiated cells at 15 h. Notably, DNA-PKcs deficient cells show a more pronounced 
G2 arrest after irradiation with the same doses when compared to the cell line with 
competent DNA-PKcs. Thereby, the increase in G2 fraction and the maximum of G2 
percentage appears at later times. Slower recovery is observed at lower doses 
(0,5Gy and 1Gy IR), while with increasing the dose the cells fail to recover from the 
checkpoint-mediated arrest until 30 hours later. As outlined above, this response 
reflects activation of the G2 checkpoint response predominantly in cells sustaining 
damage in S phase of the cell cycle. 
 
Figure 13: DNA-PKcs deficiency is associated with pronounced G2 arrest. Exponentially 
growing M059K and M059J cells were exposed to different doses of IR and harvested every 
3 hours. Cell cycle distribution was analyzed by single-parameter flow cytometry. The 
percentage of cells in G2 is represented as a function of time. Data are compiled from two 
independent experiments (± SD). 
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This observation is also confirmed with the phospho-histone H3 assay (Figure 14). 
M059K cells show a rapid decrease in the normalized mitotic index almost to zero at 
1h after IR, which reflects a stop in cell progression from G2 into M phase. 
Progression to mitosis continues after the 2-hour time point and reaches control 
levels at 4 hours. This response represents induction of the G2 checkpoint specifically 
in cells irradiated in G2 phase, as predominantly G2 cells reach M-phase within the 
timeframe of the experiment. In marked contrast to repair-proficient cells, the 
recovery from the G2 checkpoint in DNA-PKcs deficient cells remains incomplete at 
the same times after irradiation suggesting DNA-PKcs dependence for the 
checkpoint response activation. This data are in agreement with another study, 
where the lack of DNA-PKcs is associated with persistent S phase checkpoint (174). 
Interestingly, the deficiency of several other components of classical NHEJ 
(Ligase IV, XRCC4 and KU80) fail to reproduce the phenotype of DNA-PKcs deficient 
cells (174). Since all of these mutants have a strong DNA repair defect, the lack of 
recovery in DNA-PKcs deficient cells cannot be explained exclusively by the repair 
deficiency. 
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Figure 14: DNA-PKcs is required for recovery from G2/M checkpoint after IR. The 
percentage of mitotic cells positive for H3pS10 normalized to the non-irradiated control is 
represented as a function of time after exposure to IR. Data from two independent 
experiments are presented (± SD). 
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The nature of DNA-PKcs activation and its role at DSB ends to orchestrate DNA 
repair raises a question whether chemical inhibition of DNA-PKcs kinase activity in 
M059K cells would have the same response as DNA-PKcs deficiency in M059J cells. 
DNA-PKcs inactivation on cellular level is achieved by using specific small molecule 
inhibitors. Early generation of classical non-specific PI3K inhibitors involves 
Wortmannin, which is a non-competitive inhibitor that binds covalently to the kinase 
active site and was widely used in prior publications (208).  Novel ATP-competitive 
inhibitors like NU7026 and NU7441 were found to be highly specific for DNA-PKcs 
(209-211). 
For the experiments in this thesis, NU7441, a selective inhibitor of DNA-PKcs (to be 
referred as DNA-PKi), was used. The results shown on Figure 15 A clearly 
demonstrate that chemical inactivation of DNA-PKcs also results in persistent G2 
checkpoint indicating the essential function of DNA-PKcs kinase activity in the 
recovery from IR-induced cell cycle arrest (Figure 15 A, left panel). The off-target 
effect of DNA-PKi was ruled out by the experiment with M059J cells where NU7441 
is ineffective (Figure 15 A, right panel). 
The activation of the damage induced G2 checkpoint is associated with the activity of 
ATM or ATR protein kinases. To elucidate which one of the remaining PIKK kinases 
is involved in the hyper-activated G2 checkpoint in DNA-PKcs deficient cells, specific 
ATM (KU55933) and ATR (VE821) small molecule inhibitors were used (to be 
referred as ATMi and ATRi, respectively). Although ATMi prolongs the checkpoint in 
DNA-PKcs proficient M059K cells irradiated in S-phase, it shows no effect in M059J 
cells (Figure 15 B). The results with this inhibitor indicate that ATM is not involved in 
the maintenance of the prolonged checkpoint in DNA-PKcs deficient cells and implies 
the contribution of ATR. As expected, ATRi completely abrogated the G2 checkpoint 
in M059J cells, as well as in DNA-PKcs proficient M059K cells irradiated in S-phase 
(Figure 15 C). 
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Figure 15: Effect of PIKK inhibitors on the G2 arrest in M059K and M059J cells after 
exposure to IR. Actively growing M059K and M059J cells were pre-treated with different 
PIKK inhibitors 1 h prior to IR and maintained in the medium for the duration of the 
experiment (24 hours). Cells were harvested every 3 hours until 12 h following IR treatment 
and subjected to cell cycle analysis by flow cytometry. (A) 5 µM DNA-PKcs inhibitor NU7441, 
(B) 10 µM ATM inhibitor KU55933, (C) 5 µM ATR inhibitor VE821. Data presented from one 
experiment. 
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These observations reveal a possible cross-talk between DNA-PKcs and ATR in 
checkpoint signaling. Furthermore, the effect of DNA-PKcs deficiency, as well as 
DNA-PKcs inhibition seems to be stronger than that of ATM, which is thought to be a 
master conductor of the G2 checkpoint response after induction of DNA damage by 
IR exposure. Interestingly, loss of ATR activity triggers normal progression of the 
cells through the cell cycle after IR. These results suggest that DNA-PKcs augments 
recovery from checkpoint arrest after exposure to IR and thus implicates DNA-PKcs 
in the regulation of checkpoint signaling together with ATM and ATR. 
4.2. ATR regulates the G2 checkpoint by integrating inputs from ATM and 
DNA-PKcs 
Since M059K and M059J are both malignant glioma-derived cell lines, the effects of 
PIKK inhibitors on G2/M checkpoint were next studied in the normal human fibroblast 
cell line 82-6 immortalized with hTERT (human telomerase reverse transcriptase) 
expression vector. This experiment was designed not only to answer the question 
whether these effects are cell type-specific, but also to verify the unexpected role of 
ATR on IR-induced checkpoint response in non-cancer cells. Another parameter 
included in this experimental setup was the applied dose (DSB-load), where cells 
were exposed to low (i.e. 2Gy) and high doses (i.e. 10Gy) of IR. 
The results reveal that incubation of normal cells with DNA-PKi delays the recovery 
from the G2 checkpoint after IR, while ATM inhibition leads to abrogation of the G2 
arrest at early time points post irradiation and moderate but persistent reduction of 
the mitotic index at later times. At 1 to 2h after IR, ATRi has similar effect to ATMi, 
but in contrast to ATMi, at later times ATRi results in control levels of mitotic cells, 
suggesting complete abrogation of the checkpoint response (Figure 16 A). These 
results are in line with the effects observed in M059K cells (Figure 15). Combinations 
of the PIKK inhibitors show that the DNA-PKi effect is abrogated either by ATMi or by 
ATRi indicating that the hyper-activated checkpoint due to the DNA-PKcs deficiency 
is abolished when ATM and/or ATR are inactive (Figure 16 B). Furthermore, 
combined treatment with ATRi and ATMi reveals that DNA-PKcs alone is not able to 
sustain IR-induced checkpoint. Interestingly, the ATM inhibitor shows a dose-
dependent effect on checkpoint activation, as the higher dose of 10Gy further 
influences the outcome observed after irradiation with 2Gy (Figure 16 A, C). The 
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same response is observed with the combined treatment of DNA-PKi and ATMi 
(Figure 16 B, D). After 10Gy of irradiation, ATR inhibition results in a small initial 
drop followed by rapid increase in the mitotic index above normal levels, which may 
be explained by accumulation of cells at the G2/M border due to the higher dose and 
their subsequent progression as an ensemble into mitosis. At a higher dose, either 
ATM or ATR alone are capable of activating moderately the G2 checkpoint response 
(Figure 16 D, green and red lines respectively). The data suggest that the other 
remaining kinases ATM and DNA-PKcs cannot contribute to checkpoint development 
without ATR since they both remain active when ATRi is applied. 
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Figure 16: Multiple drugs effects on G2/M progression of normal human fibroblasts 
after IR. Cells were treated with 5 µM NU7441 (DNA-PKcsi), 10 µM KU55933 (ATMi) and 
5 µM VE821 (ATRi) 1 hour prior to IR. Cells were harvested at different time intervals after 
exposure to IR. Data obtained from two independent experiments (± SD). 
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All these results also suggest that ATR is not a minor contributor to G2 checkpoint 
development and implicate the essential role of ATR for the manifestation of the G2 
checkpoint in cells sustaining damage in G2 phase.  Furthermore, the data imply that 
all three PIKK kinases may work as a module to regulate the DNA damage signaling 
and checkpoint response following exposure of cells to IR. In line with the above 
postulate, chemical inactivation of the kinase activity of the entire module leads to 
completely abrogated G2 checkpoint independent of the radiation dose (Figure 16 
B, D).  
Further confirmation of the importance of the ATR arm of the G2 checkpoint activation 
came from the results with inhibitor of the ATR-downstream kinase CHK1, UCN-01 
(referred as CHK1i). As shown on Figure 17, inhibition of CHK1 results in a 
remarkable, although no complete, reduction of G2 checkpoint, which suggests a 
cross-talk between ATR and CHK2. On the other hand, CDC25 may also become 
phosphorylated since the ATM-CHK2 arm is still active. However, this residual 
checkpoint could not be completely abrogated by inhibiting CHK2, although it was 
entirely reversed by ATM inhibition at a low dose (Figure 17, left panel). The same 
response was observed in M059J cell line (Figure 18). 
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Figure 17: Multiple drugs effects on G2/M progression of normal human fibroblasts 
after IR. Cells were pre-treated with 100nM Chk1i (UCN-01), 400nM Chk2i and 10 µM ATMi 
(KU55933). Data presented from one experiment. 
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Figure 18: Multiple drugs effects on G2/M progression of M059J cells after IR. Cells 
were treated with 100nM Chk1i (UCN-01), 400nM Chk2i and 10 µM ATMi (KU55933) 1 hour 
prior to irradiation. Data obtained from two independent experiments (± SD). 
 
Since the hyper-activated G2 checkpoint in DNA-PKcs-deficient cells is dependent on 
ATR activity and ATR requires DNA end resection at IR-generated DSBs, the 
hypothesis arose that under basal conditions resection is downregulated by 
DNA-PKcs. This implies that absence of DNA-PKcs leads to hyper-resection, which 
provokes ATR hyper-activation. Therefore, the next part of the thesis focuses on the 
role of DNA-PKcs in the process of DNA-end resection. 
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Part 2: Contribution of DNA-PK to the regulation of DNA-end resection 
4.3. DNA-PKcs deficiency is associated with enhanced DNA end resection in 
G2 phase 
Next, to test the above hypothesis, the rate of DNA-end resection was studied in 
DNA-PKcs deficient cell line M059J and its counterpart M059K. RPA accumulation at 
the ssDNA overhangs was used as a read-out for ongoing DNA end resection. RPA 
foci were visualized in a population of irradiated G2 cells selectively discriminated by 
Cyclin B1 staining. It is well documented that the Cyclin B level oscillates throughout 
the cell cycle with a maximum in S/G2 phase and during mitosis, where Cyclin B1 is 
localized at the microtubules (212). Analysis of DNA end resection by IF revealed 
that the RPA70 foci number in DNA-PKcs deficient cell line is greatly increased as 
compared to the repair proficient cells (Figure 19). 
A        B 
     
Figure 19: Immunofluorescence analysis of RPA70 foci number in M059K and M059J 
cells. (A) Kinetics of RPA70 foci formation in Cyclin B1 positive cells following exposure to 
4Gy IR. Foci were scored in >30 nuclei per slide. (B) Representative immunofluorescence 
images of RPA70 foci (green) in Cyclin B1 positive cells (red). Nuclei were counter-stained 
with DAPI (blue). Representative data from one out of two independent experiments (± SE). 
This observation indicates that under default conditions, DNA-PKcs may suppress 
DSB end resection in G2 phase of the cell cycle. Therefore, in cells with DNA-PKcs 
deficient background the balance of DSB repair may be shifted toward HRR and a-EJ 
pathways that profit from resected DNA. 
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4.4. The role of KU heterodimer on end resection in M059K and M059J cells 
KU70/80 binds directly DSB ends and serves as an anchor point for NHEJ proteins. 
Therefore, multiple previous studies assign functions to KU heterodimer, which 
include suppression of DNA end resection (213, 214). As KU70/80 is an integral part 
of the DNA-PK holoenzyme, we wished to investigate whether KU70/80 deficiency 
provokes similar responses as DNA-PKcs on DNA end resection. To investigate the 
role of KU heterodimer in the process of DNA end resection, we used siRNA-
mediated depletion of KU70 in M059K and M059J cells. 
As shown in Figure 20 C, the expression of KU70 can be reduced significantly by 
specific siRNA targeting KU70 mRNA. Both M059K and M059J cells transfected with 
siRNA against KU70 show reduced level of KU70 protein up to 48 hours after 
nucleofection® when compared to the control. However, the results from an 
immunofluorescent experiment with repair-proficient M059K cells do not show a 
significant increase of RPA foci number in KU70-depleted cells when compared with 
the mock-transfected control (Figure 20 A, left panel). This result does not resemble 
the effect of DNA-PKcs deficiency on RPA foci formation and argues against the 
negative role of KU70/80 on initiation of DNA end resection. Similarly, siRNA-
mediated depletion of KU70 on top of DNA-PKcs deficiency (Figure 20 A, right 
panel) did not further increase RPA foci number at any of the time points following 
exposure to IR. In addition to RPA foci formation, the RPA foci intensity did not differ 
significantly between mock and siKU70-treatments in both cell lines, but the higher 
number of RPA foci in M059J cells is associated with a slightly increased foci 
intensity when compared to M059K cells (Figure 20 B). 
In summary, these results show that KU70/80 alone is not sufficient to suppress the 
initiation of end resection under normal conditions and reinforce the notion that 
DNA-PKcs suppresses end resection independently of KU heterodimer. 
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Figure 20: Effect of KU70 knock-down on DNA end resection. Analysis of RPA70 foci 
number (A) and intensity (B) in M059K and M059J cells. Foci number from the 
corresponding unirradiated controls at each time point was subtracted. In the mock-treated 
control cells were subjected to Nucleofection® in the absence of siRNA. The dashed lines 
serve to show the different levels of intensity values between the two cell lines. (C) 
Verification of KU70 knock-down by western blot 48 h after nucleofection®. 10 µg and 20 µg 
of total protein were loaded. Data obtained from one experiment (± SE). 
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4.5. DNA-PKcs actively regulates resection and G2 checkpoint 
To study the contribution of each component of the DNA-PK holoenzyme to the end 
resection process in more detail, an experiment in repair-proficient cell line M059K 
was designed applying RNA interference (RNAi) to reduce the gene expression of 
KU combined with a specific inhibitor of DNA-PKcs. This approach could answer the 
question whether the catalytic function of DNA-PKcs alone is necessary to suppress 
end resection. For a better comparison of the foci number in M059K cells, the dose of 
IR was increased from 2Gy in the previous experiment (Figure 20) to 4Gy. The 
remaining cells from each time point were analyzed by flow cytometry to monitor the 
G2 arrest. 
The results indicate that the level of KU70 stays relatively low even 72h after 
transfection with specific siRNA. Additionally, the knock-down of KU70 is associated 
with decreased expression of KU80 (Figure 21 B). The foci kinetics show a 
maximum RPA foci number at 6 hours after irradiation with 4Gy, and that the 
absence of KU70/80 does not significantly increase RPA foci number at later times 
post IR (Figure 21 A). This indicates that KU70/80 does not impair DNA end 
resection by blocking the DSB ends. Inactivation of DNA-PK catalytic subunit by 
NU7441 does not completely replicate the phenotype observed in M059J cell line in 
terms of RPA foci number. However, the DNA-PKcs inhibitor augments the RPA foci 
formation at later time points following exposure to radiation. Treatment with 
DNA-PKcs inhibitor on top of KU70/80 knock-down did not further alter RPA foci 
kinetics. Since in this experimental setup DNA-PKcs is present but catalytically 
inactive, these findings suggest that DNA-PKcs may actively regulate the end 
resection process through its catalytic function. This observation is confirmed by RPA 
foci kinetics in kinase-deficient CHO cells (unpublished data from our laboratory). 
Once bound to the DSB ends, DNA-PKcs needs phosphorylation in order to detach 
from the break. Therefore, the delayed increase in RPA foci number in the presence 
of DNA-PKcs inhibitor implies that other kinases may contribute to the initial 
phosphorylation of DNA-PKcs. A possible candidate is ATM, which was shown to 
mediate DNA-PKcs phosphorylation at the Thr-2609 cluster (165). 
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Figure 21: The role of DNA-PK holoenzyme on end resection in repair-proficient cells. 
(A) Kinetics of RPA70 foci formation in Cyclin B1 positive cells. Mock-transfected cells were 
subjected to nucleofection® program X-01 in the absence of siRNA and a fraction of these 
cells was treated with 5µM DNA-PKcs inhibitor NU7441. The foci number from the 
corresponding unirradiated controls at each time point was subtracted. (B) Western blot 
analysis of KU70 knock-down efficiency associated with decreased expression of KU80. 
Protein extracts were isolated on the day of experiment, 48h after nucleofection®. (C, D) G2 
arrest analysis by flow cytometry. Representative data from one out of two independent 
experiments. 
 
Since KU70/80 appears to not regulate negatively resection under our experimental 
conditions, we speculated the effect of DNA-PKcs deficiency on G2 checkpoint is 
DNA-PKcs-specific and not the result of c-NHEJ deficiency. Therefore, the remaining 
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cells from each sample were subjected to flow cytometry analysis to confirm that the 
G2 checkpoint is not abrogated by KU70/80 depletion. 
As shown on Figure 21 C, D, depletion of KU heterodimer does not affect the 
accumulation of cells in G2 phase. In contrast, inhibition of DNA-PKcs results in 
prolonged G2 arrest in non-depleted as well as in KU70/80-depleted cells. 
In summary, the results in this section further support the notion that the catalytic 
subunit of DNA-PK may work independently of KU70/80 to regulate end resection 
and G2 checkpoint development through its catalytic function. 
4.6. Contribution of ATM and ATR to DSB end resection in the absence of 
DNA-PKcs 
The unexpected role of ATR in G2 checkpoint activation in response to ionizing 
radiation implies that ATR is dominantly involved in DNA damage recognition and 
checkpoint along with ATM and only not partially as frequently assumed. Another 
indication supporting this hypothesis comes from M059J cells, where the ATM level is 
reported to be post-transcriptionally reduced due to over-expression of miR-100 
(microRNA 100) (215). Under these conditions, ATR may play a more prominent role 
in regulating resection. However, ATM signaling in M059J cells was shown to be 
intact (unpublished data from our laboratory). 
To further study the sequence of PIKK kinase contribution to end resection, an 
experiment was designed, where M059J cells were treated with ATMi and ATRi 
1 hour before or 30 minutes after IR and RPA foci formation was monitored up to 9 
hours after damage induction. The results show that RPA foci reach their maximum 
3-6 hours after irradiation (Figure 22). Pre-treatment with ATMi delays significantly 
RPA70 foci formation after IR indicating the essential function of ATM in the initiation 
of DNA-end resection (Figure 22 A, left panel). Although the level of ATM in 
DNA-PKcs deficient cells is low, ATM activity is evidently sufficient to trigger this 
process. This result also shows that ATR alone is not capable to initiate end 
resection at IR-induced DSBs in G2 irradiated cells. Nevertheless, inactivation of ATR 
also reduces RPA70 foci number at the initial times after IR (1-3 hour window) 
implicating ATR also in initiation of the DNA-end resection. Chemical inhibition of 
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both ATM and ATR on top of DNA-PKcs deficiency provides the same response on 
RPA foci kinetics as ATMi alone. 
Treatment with ATMi 30 min after exposure of cell to IR does not affect RPA foci 
number indicating that even after this short time after damage induction, the ATM-
dependent contribution to signaling and resection regulation is completed. In 
contrast, inactivation of ATR 30 min post-IR diminishes significantly the number of 
RPA foci (Figure 22 A, right panel). These results show the key role of ATM for 
triggering the DNA damage signaling cascade and the response of ATR to ssDNA-
RPA structures. 
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Figure 22: Effect of PIKK kinase inhibitors on RPA foci formation in M059J cells. Cells 
were treated with inhibitors 1 hour before (left panel) and 30 minutes after irradiation (right 
panel). ATM and ATR kinase activity was inhibited by 10µM KU55933 and 5µM VE821, 
respectively, and the inhibitors were left in the media for the duration of the experiment. (A) 
Kinetics of RPA70 foci formation in Cyclin B1 positive cells following exposure to 2Gy. Foci 
were scored in >30 nuclei per slide. (B and C, see below) Representative 
immunofluorescence images of RPA70 foci (green) in Cyclin B1 positive cells (red). Nuclei 
were counter-stained with DAPI (blue). Data obtained from two independent experiments 
(± SD). 
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Figure 22B: Representative immunofluorescence images of RPA70 foci corresponding 
to Figure 22A, left panel 
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Figure 22C: Representative immunofluorescence images of RPA70 foci corresponding 
to Figure 22A, right panel 
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4.7. ATR is required for resection in G2 phase in normal cells 
Based on the observations that ATR may have a central role in G2 checkpoint 
development under normal conditions, its activation by ssDNA-RPA structures must 
be essential. 
To further explore the potential role of ATR in regulating the generation of ssDNA-
RPA intermediates under normal conditions, similar experiments were performed 
with normal human fibroblast cell line 82-6 immortalized with hTERT using ATRi 
(Figure 23). Normal cells exposed to 4Gy of IR show similar response in terms of 
RPA foci kinetics as M059J cells exposed to 2Gy (Figure 20). 
2.5µM ATRi does not affect RPA foci formation, whereas 5µM and 10µM of ATRi 
show similar response to that observed in M059J cells, with RPA foci numbers being 
reduced by a factor of 2. Pre-treatment with 20µM ATRi completely abolishes RPA 
foci formation. These results clearly show the attenuation of RPA foci formation with 
increasing concentrations of ATRi reflecting abrogated signaling at DSB ends in 
absence of ATR catalytic activity despite the presence of ATM activity. Data from our 
laboratory have shown that the number and intensity of phospho-ATM foci, as well as 
phosphorylation of CHK2 on Thr68, remain unaffected by ATRi or CHK1i. Seckel 
syndrome cells also exhibit intact ATM function (216). 
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B 
 
Figure 23: Effect of ATR inhibition on RPA foci formation in normal human fibroblasts. 
82-6 cells were pre-treated with different concentrations of ATR inhibitor VE821 1h before 
exposure to IR and the inhibitor was left in the media for the duration of the experiment. Cells 
were collected at different time intervals after damage induction. The foci number from the 
corresponding unirradiated controls at each time point was subtracted. Data obtained from 
one experiment. (A) Kinetics of RPA70 foci formation in Cyclin B1 positive cells following 
exposure to 4Gy IR. (B) Representative immunofluorescence images of RPA70 foci (green) 
in Cyclin B1 positive cells (red). Nuclei were counter-stained with DAPI (blue). 
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4.8. Identifying factors involved in the elevated DSB end resection in DNA-
PKcs deficient cells 
To find out whether DNA-PKcs regulates the activity of enzymes responsible for DSB 
end resection, a screening of knockdowns of proteins involved in this process was 
performed – it comprised CtIP, MRN, EXO1 and DNA2. As repair-proficient cells in 
this experimental design we used normal human fibroblasts 82-6 hTERT. 
CtIP has been implicated in initiating DSB end resection, homologous recombination 
and checkpoint signaling (74). The results show that depletion of CtIP (Figure 24) 
significantly reduces RPA70 foci formation in both cell lines (Figure 25). 
 
Figure 24: Western blot analysis of siRNA-treated M059J cells. Verification of CtIP (A), 
MRE11 (B) and NBS1 (C) knock-down efficiency 48 hours after transfection with siRNA. 
Equal amounts of total protein were loaded per lane (50µg for CtIP, 20µg for MRE11 and 
30µg for NBS1 detection). Mock-transfected cells were subjected to nucleofection® program 
X-01 in the absence of siRNA. For siRNA-mediated depletion of NBS1 were tested two 
siRNA sequences. Samples were separated on 10% SDS polyacrylamide gel. 
 
The MRN complex is engaged in sensing and signaling of DSBs and has been 
shown to operate in cooperation with CtIP (217). MRE11 has exo- and endonuclease 
activity. Therefore, we next sought to knock-down MRE11 and NBS1. The data show 
that although a sufficient level of knock-down of NBS1 was achieved (Figure 24) 
RPA70 foci formation was decreased in 82-6 hTERT, but not in M059J cells Figure 
26). 
Similarly, the level of MRE11 depletion was efficient, but did not affect RPA70 foci 
number in any of the cell lines. However, indicative results were achieved when using 
the MRE11 inhibitor Mirin in combination with siMRE11, where pronounced effects 
on resection were recorded (Figure 26 A, B). 
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Figure 25: Effect of siRNA-mediated knock-down of CtIP on RPA foci formation. (A) 
RPA foci were scored in 82-6 hTERT and M059J cells positive for Cyclin B1 staining. Mock-
nucleofection® was performed in the absence of siRNA. RPA foci formation was followed at 
48 hours after transfection. Representative data from one experiment (82-6 hTERT) and one 
out of two (M059J) experiments (± SE). (B) Representative immunofluorescence images of 
RPA70 foci (green) in Cyclin B1 positive cells (red). Nuclei were counter-stained with DAPI 
(blue). 
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A possible explanation for MRE11 depletion alone results is that residual activity is 
sufficient for the observed effect. The double knock-down of MRE11 and NBS1 did 
not further affect RPA foci number (Figure 26 B, lower panel). 
These observations identify MRN complex and CtIP as potential targets of DNA-PK 
catalytic subunit in the regulation of end resection under normal conditions. Next, we 
examined long-range resection mediated by EXO1 and DNA2. 
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Figure 26: Contribution of MRN complex to DSB end resection. To evaluate the effect of 
MRN complex on RPA foci formation was applied mRNA interference targeting MRE11 and 
NBS1, as well as MRE11 inhibitor Mirin (75 mM). RPA foci were scored in 82-6 hTERT (A) 
and M059J (B) cells positive for Cyclin B1 staining. Mock-treated cells were exposed to 
nucleofection® in the absence of siRNA. Cells were irradiated 48 hours after transfection 
with siRNA. Data obtained from one experiment (± SE). 
 
RPA70 foci formation was not attenuated in M059J cells transfected with different 
siRNA sequences against EXO1, rather RPA foci number becomes higher at the 
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6-hour time point after IR. Due to technical difficulties, EXO1 and DNA2 knockdowns 
could not be validated by western blotting. The effect of EXO1 depletion could be 
demonstrated in repair-proficient cells, where RPA foci were diminished (Figure 
27 A). 
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Figure 27: Effect of siRNA-mediated knock-down of EXO1 (A) and DNA2 (B) on RPA 
foci formation. RPA foci were scored in 82-6 hTERT and M059J cells positive for Cyclin B1 
staining 48 hours after transfection with siRNA (± SD). Mock-nucleofection® was performed 
in the absence of siRNA. Data obtained from one experiment (± SE). 
A similar effect is observed in Exo1-deficient cells (Figure 28), where RPA foci follow 
similar kinetics as observed in EXO1-depleted cells. In contrast, siRNA-mediated 
knockdown of DNA2 leads to very strong effect on RPA foci number in both 82-6 
hTERT and M059J cells Figure 27 B. 
In summary, CtIP, MRN complex and DNA2 stand out as strong candidates to be 
regulated/phosphorylated by DNA-PKcs. 
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In conclusion, our results provide evidence that DNA-PKcs regulates actively the G2 
checkpoint response and end resection, a function that does not require the KU70/80 
DNA binding factor. 
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Figure 28: Effect of Exo1 deficiency on RPA foci kinetics. Insertion of Hygromycin 
cassette between exons 4 and 5 leads to disruption of Exo1 gene locus in mouse embryonic 
fibroblasts (MEF) cells (218). Immunofluorescent Cyclin B1 staining in mouse cells was not 
successful, therefore the analysis of this this experiment were considered only cells with foci. 
Data obtained from one experiment (± SE). 
 
In addition, our data suggest that in G2 phase cells both ATM and ATR are required 
to sustain the checkpoint in response to DSBs since loss of either ATM or ATR 
causes its abrogation. At higher doses, this dependency is not present. Even more, 
ATR might not be a passive responder to ssDNA, rather ATR also regulates the end 
resection process. 
Collectively, these data point to a kinase module consisting of ATM, ATR and DNA-
PKcs, which regulates and fine-tunes the DNA damage response. 
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5. DISCUSSION 
5.1. Contribution of DNA-PKcs to G2 checkpoint response 
DNA-PKcs is considered a key factor for c-NHEJ but not a component of checkpoint 
signaling. Our results, however, show that DNA-PKcs deficiency or chemical 
inactivation results in a hyper-activated checkpoint in cells sustaining damage in both 
S and G2 phase of the cell cycle suggesting that DNA-PKcs plays an important role in 
checkpoint recovery. Inhibition of DNA-PKcs activity has even higher impact on G2 
arrest and decrease of the mitotic index than that of ATM inactivation in both S and 
G2 phase cells. In DNA-PKcs deficient cells, the recovery from the checkpoint at 
0.1Gy and 0.5Gy is possible although the checkpoint is dramatically prolonged. 
Interestingly, lack of recovery is observed with increasing radiation dose (i.e. at 1Gy 
and 2Gy). This means that at higher doses of IR the ATM/ATR component is over-
activated, which is consistent with the observation that the hyper-activated G2 
checkpoint in DNA-PKcs deficient cells is ATR-dependent in S phase cells, and 
ATM/ATR dependent in G2 phase irradiated cells.  
Checkpoint activation in G2 provides additional time for repair. In contrast to HRR, 
c-NHEJ is not considered to benefit from checkpoint signaling (69, 70). Our 
observations imply that DNA-PKcs does not control directly checkpoint activation 
through downstream kinases; rather under normal conditions DNA-PKcs forestalls 
the process of DNA end resection which triggers ATR and checkpoint activation. This 
is consistent with the major role of ATR in G2 checkpoint response. DNA-PKcs 
deficiency, however, could prolong the time required for repair, as more breaks are 
resected and would require HR or a-EJ. This would be an indirect contribution of 
DNA-PKcs to G2 checkpoint control. 
Given the c-NHEJ deficiency of M059J cells, one may speculate that the enhanced 
G2 checkpoint activation in these cells is not coupled with DNA-PKcs-deficiency itself; 
rather this mirrors the extended repair time required by HRR and a-EJ and the higher 
DSB load shunted in these repair pathways. However, reduced levels of KU70/80 in 
repair-proficient M059K cells did not affect checkpoint development. Iliakis and 
colleagues also have shown that the lack of recovery of IR-induced replication arrest, 
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representing the activation of the S-phase checkpoint, is DNA-PKcs-specific as it is 
not observed with other components of c-NHEJ (174). 
Since DNA-PKcs deficiency is associated with reduced expression of ATM (219), it 
might be that the enhanced G2 checkpoint on DNA-PKcs deficient background is due 
to the low level of ATM. Yet, the ATM level in M059J cells seems to be sufficient for 
signaling since DNA end resection is significantly abrogated by treatment with ATM 
inhibitor. In addition, combined treatment of 82-6 fibroblasts with DNA-PKcs and ATM 
inhibitors completely abrogated the persistent checkpoint induced by DNA-PKcs 
inhibitor alone, as measured by H3pS10 assay. Moreover, Tomimatsu et al. 
demonstrated the contribution of DNA-PKcs to the development of ATR-mediated 
checkpoint in ATM-deficient cells, where DNA-PKcs was shown to phosphorylate 
proteins involved in chromatin remodeling like KAP-1 (176). 
Alternatively, DNA-PKcs may contribute actively to G2 checkpoint regulation through 
direct interactions with ATM/ATR. Evidence suggests that in response to replication 
stress DNA-PKcs is required for optimal ATR-CHK1 signaling by regulating CHK1 
protein expression and stability of CHK1-Claspin complex (220). In vitro studies by 
Vidal-Eychenie et al. also describe interactions between DNA-PKcs and ATR. In their 
proposed model KU mediates the recruitment of DNA-PKcs to the break, which in 
turn phosphorylates RPA and promotes ATR activation (221). Hence, abrogation of 
RPA phosphorylation sites by Alanine residues or treatment with DNA-PKcs inhibitor 
would affect ATR activation and therewith the checkpoint response, which is indeed 
not in line with all of our observations. This speculation needs to be carefully 
examined in vivo. 
ATM was also shown to be required for the full phosphorylation-mediated activation 
of DNA-PKcs upon IR where ATM is critical for the phosphorylation of Thr-2609 
cluster of DNA-PKcs (165). Whether abrogation of this phosphorylation event 
influences the G2 checkpoint activation and maintenance by affecting DNA-PKcs 
activity deserves further investigation. 
In summary, the prolonged checkpoint response observed under DNA-PKcs 
deficiency in cells sustaining damage in S phase is dependent on ATR. In contrast, 
this checkpoint activation in G2 phase cells is abrogated by either ATM or ATR 
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inhibition, as well as by inactivation of the downstream kinases CHK1 and CHK2. 
These observations, combined with the data in the literature, suggest a functional 
crosstalk between DNA-PKcs and ATM/ATR in order to effectively control the G2 
checkpoint. The coordination within the module is abrogated by inhibition of any of 
these kinases, where only DNA-PKcs deficiency results in prominent G2 checkpoint 
arrest - an effect that seems not to be coupled with c-NHEJ deficiency. 
5.2. DNA-PKcs influences the G2 checkpoint activation and maintenance 
through regulation of DNA end resection 
Absence of DNA-PKcs in M059J cells shuttles the DSBs into HRR or a-EJ, which 
operate with slower kinetics that c-NHEJ. Therefore, the hyper-activated checkpoint 
response in absence of DNA-PKcs would be favorable for repair pathways that need 
time. RPA foci analysis by immunofluorescence is an established method for 
measuring the accumulation of RPA to ssDNA, which is used as a readout for DNA 
end resection during homologous recombination, and also activates the ATR/CHK1 
signaling pathway. Interestingly, the increased resection in M059J system correlates 
with the enhanced G2 checkpoint response. 
The higher number of RPA foci in DNA-PKcs deficient cells suggests that under 
normal conditions DNA-PKcs suppresses end resection in G2 phase and therewith 
homologous recombination. This agrees with a study by Nickoloff and colleagues, 
showing that DNA-PKcs suppresses HR as measured by HR substrates containing 
I-SceI sites in DNA-PKcs defective Chinese hamster ovary (V3) cells and isogenic 
derivatives complemented with human DNA-PKcs cDNA. Complementation of DNA-
PKcs resulted in lower levels of both DSB-induced and spontaneous HR frequencies 
(222). Moreover, DNA-PK’s ability to suppress HR was shown to be dependent on its 
kinase activity, where its phosphorylation status is thought to help define the repair 
pathway choice. Thereby, phosphorylation of the ABCDE cluster seems to be of 
great importance for promoting HR, while phosphorylation of the PQR cluster would 
inhibit it (135, 138).  
Moreover, unpublished data from our laboratory have shown that RAD51 foci in 
DNA-PKcs deficient M059J cell line also increase, when compared to repair-
proficient M059K cells, and remain unresolved at later time points after IR, meaning 
 _____________________________________________________________________________ DISCUSSION 
 
74 
 
that HR in M059J cells could be aberrant. A study by Dip and Naegeli has shown that 
DNA-PKcs can recognize and associate with synthetic four-way Holliday junctions 
independently of KU70/80 and DNA ends (223). Given the higher residual number of 
RAD51 foci in M059J cells, this suggests that DNA-PKcs deficiency may be 
associated with abrogation of homologous recombination at the step of Holliday 
junction resolution. It is therefore plausible that DNA-PKcs may also regulate proteins 
involved in branch migration or Holliday junction resolution during homologous 
recombination. Hence, in cells with DNA-PKcs deficient background the persistent 
RPA foci may result from branch migration in the wrong direction. 
Since HR requires extensive chromatin modifications, it is also possible that HR is 
abrogated in the absence of DNA-PKcs because more breaks are committed to be 
repaired by HR and chromatin opens up which may destabilize it. This assumption is 
supported by the higher residual number of γH2AX foci associated with DNA-PKcs 
deficiency (unpublished data from our laboratory). 
The kinetics of RPA foci formation in repair-proficient M059K cells treated with the 
DNA-PKcs inhibitor does not completely resemble the phenotype observed in M059J 
cells where DNA-PKcs is absent.  Increase of RPA foci number is observed at later 
times, which may be explained by NU7441 preventing DNA-PK’s auto-
phosphorylation and therewith its dissociation from the ends. Blocking the DNA ends 
in turn may hamper not only NHEJ but also HR by restricting the function of 
exonucleases. Nevertheless, the data from this experiment further imply that the 
catalytic activity of DNA-PKcs suppresses extensive resection of the DSB ends. 
The experiments with siRNA-mediated KU70 knockdown in M059K cells provide 
evidence that DNA-PKcs may be activated in the absence of its regulatory subunit 
KU70/80, which is believed to recruit DNA-PKcs to DNA ends. Together, these 
results lead to a possible model shown on Figure 29 (1), where under normal 
conditions DNA-PKcs downregulates resection independently of KU70/80. 
Nevertheless, it could be that despite the marked reduction of KU70/80 expression 
by approximately 90 %, very low level of KU70/80 is needed to secure recruitment of 
DNA-PKcs to DSBs. Indeed, this model is further supported by the evidence 
suggesting that under low salt conditions DNA-PKcs is capable of binding DNA ends 
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and becomes activated independently of KU70/80 (144). Meek et al. also reported a 
strong enzymatic activation of DNA-PKcs independently of DNA and KU70/80 
through a conformational change of its N-terminus (162). 
(2) The substantial increase of RPA foci in DNA-PKcs deficient cells leads to a 
second hypothesis suggesting that once KU70/80 is bound to DNA, the absence of 
DNA-PKcs may be favorable for the recruitment of other DNA repair factors. There is 
data suggesting that the KU-MRE11 interaction after IR is stronger under these 
conditions (224), although other studies show the opposing results (99). It is 
therefore conceivable that loss of DNA-PKcs may potentiate the interaction between 
KU and the MRN complex, which then can recruit ATM and CtIP to initiate resection. 
Whether this possible interaction of KU-MRN is sufficient for initiating resection in the 
absence of DNA-PKcs needs to be consolidated. 
 
Figure 29: Two possible models for downregulation of DNA end resection by DNA-PK 
catalytic subunit. (1) Under basal conditions, DNA-PKcs may regulate end resection in G2 
phase independently of KU70/80. (2) Resection factors might gain profit from the absence of 
DNA-PKcs. 
 
 
 _____________________________________________________________________________ DISCUSSION 
 
76 
 
Nevertheless, the KU heterodimer was reported to negatively regulate HRR by 
blocking the ends for resection (214, 225). Moreover, KU deficiency was shown to be 
associated with remarkably increased DSB-induced HR when compared to cells 
lacking DNA-PKcs, as measured using the DR-GFP reporter (226). The data from 
our experiments do not support the role of KU-binding factor alone in suppressing 
initiation of resection and HR, not only under normal conditions but also in cells with 
deficient DNA-PKcs. However, this conclusion could not be reached with mouse cells 
depleted of KU70, where deficiency of KU70 results in marked increase of RPA and 
RAD51 foci number in comparison to the control (unpublished data from our 
laboratory).  
While this work was in progress, an in vitro study by Zhou and Paull demonstrated 
that DNA-PKcs, together with MRN and ATM, regulates resection, where MRN can 
overcome the inhibitory activity of DNA-PKcs on EXO1 (227). Our data also link 
DNA-PKcs to MRN and CtIP in initiating resection since knockdown of either CtIP or 
abrogation of MRN activity in M059J cells reduces RPA foci number. However, the 
nuclease responsible for the long-range resection in M059J cells appears to be 
DNA2. Transfection of M059J cells with two different siRNA sequences against 
DNA2 resulted in a significant decrease of RPA foci number, while depletion of EXO1 
showed a prominent effect on RPA foci number in 82-6 fibroblasts but not in M059J 
cells. 
In conclusion, hyper-resection in DNA-PKcs deficient M059J cells shunts DSBs in G2 
phase toward HRR or a-EJ, which also explains the higher number of translocations 
in DNA-PKcs deficient cells (unpublished data from our laboratory). Our observations 
suggest that DNA-PKcs regulates the process of DNA resection, thus implicating its 
enzymatic activities in both c-NHEJ and HRR. 
5.3. DNA-PKcs-deficiency does parallel its chemical inactivation 
Our results clearly indicate that in case of G2 checkpoint small molecule DNA-PKcs 
inhibitor has identical effect on G2 arrest as the absence of DNA-PKcs protein. 
However, at the resection level, chemical inactivation of DNA-PKcs does not 
completely parallel the effect on RPA foci observed in DNA-PKcs deficient cells. The 
latter implies that enzymatically inactive DNA-PKcs associated with the break has an 
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inhibitory effect on HR by suppressing resection. This result is reminiscent of a study 
describing  an ‘interactive competition’ between HR and NHEJ by using another 
specific DNA-PK inhibitor (136). 
Consequently, DNA-PKcs may regulate checkpoint response independently of 
KU70/80. Thus, the hyper-activated checkpoint after treatment with the DNA-PKcs 
inhibitor, or DNA-PKcs deficiency, provides time for repair by HRR or a-EJ, but 
resection of DSB ends originally directed to c-NHEJ is limited since exonucleases 
have no access to the ends. This may explain why in the case of DNA-PKcs’ 
chemical inhibition in M059K checkpoint activation does not correlate with the rate of 
resection as observed in M059J cells. 
5.4. A model integrating ATR, ATM and DNA-PKcs to effectively control G2 
checkpoint and DNA end resection 
ATM is thought to be central to DNA damage signaling (39). The sequential 
engagement of ATM and ATR in DNA damage response is well described in the 
literature where ATM is believed to be the primary kinase initiating end resection 
(228, 229). It is therefore not surprising that in normal cells deficiency of ATM leads 
to abrogated checkpoint in cells sustaining damage in G2 phase. With increasing the 
DSB load, the role of ATM in sustaining the checkpoint becomes more prominent. 
ATM deficiency or inactivation of ATM activity by specific inhibitors is also associated 
with delayed formation of RPA foci. 
DSB repair by HR requires resection of the ends, which then triggers ATR activation. 
Since in higher eukaryotes only ~10-20% of the DSBs are thought to be repaired by 
HR (230), the contribution of ATR in checkpoint development in response to DSBs is 
typically thought to be limited. Although ATR is assigned to DNA replication stress 
and requires ssDNA for activation in response to DSBs, our data provide compelling 
evidence that ATR is also essential for checkpoint activation and maintenance in 
response to IR. This observation places the role of ATR beyond the replication 
checkpoint control. 
Moreover, the reduction of RPA foci number in the presence of ATR inhibitor in both 
82-6 fibroblasts and M059J cells implies that ATR may not be a passive responder to 
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resection; rather ATR might actively regulate the initiation of end resection process. 
Kousholt et al. have shown that the rapid activation of ATR downstream target CHK1 
precedes initiation of resection. In addition, CtIP-mediated end resection was shown 
to be required for the sustained checkpoint signaling but not for its initiation, which 
leads to the assumption that checkpoint activation is independent of end resection 
and points to the above indicated role of ATM (231). 
Furthermore, CHK1 inhibition results in residual checkpoint activation at the early 
time points after IR. Despite this small initial drop of the mitotic index, ATR seems to 
be involved in G2 checkpoint activation and maintenance predominantly through 
CHK1 (232). 
Since both ATM and ATR promote end resection in G2 phase and checkpoint 
response, inhibition of each of them results in abrogation of both G2 checkpoint 
response and of end resection. Unlike ATM and ATR, DNA-PKcs deficiency results in 
enhanced G2 checkpoint activation combined with excessive DSB end resection. This 
suggests that ATM/ATR and DNA-PKcs have opposing roles in the process of 
resection. Under normal conditions DNA-PKcs prevents ATR upregulation and over-
resection that may be unfavorable for c-NHEJ. The upregulation of ATR activity in 
DNA-PKcs deficient background but also in ATM deficient cells (233) suggests that 
ATM and ATR cannot substitute DNA-PKcs for the recovery from the checkpoint. 
Together, our data demonstrate the contribution of DNA-PKcs to G2 checkpoint and 
end resection suggesting that DNA-PKcs is involved in a functional kinase module 
together with ATM/ATR in order to effectively control the DNA damage response and 
optimize end processing. Based on our observations, if the DNA-PKcs component of 
this module is missing, which is also associated with reduced ATM level, the cell tries 
to ‘compensate’ for its absence via up-regulation of ATR. In addition, under normal 
conditions DNA-PKcs may regulate homologous recombination through ATR. 
Although the view about ‘mechanistic/direct competition between NHEJ and HR’ in 
DSB repair is strengthened by many publications (135, 222, 226, 234, 235), we 
suggest that pathway choice is not only dictated by the cell cycle phase and 
chromatin status; rather it is a highly regulated process by all three PIKK kinases. In 
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this module ATR seems to have a complete control on G2 checkpoint response and 
also to regulate resection. The exact mechanism remains to be elucidated. 
  
 _______________________________________________________________________________ SUMMARY 
 
80 
 
6. SUMMARY 
The data from our experiments revealed that DNA-PKcs deficiency is associated with 
persistent G2 checkpoint that in cells sustaining damage in S phase of the cell cycle 
is dependent on ATR, while in cells irradiated in G2 phase it strongly relies on both 
ATM/ATR. The hyper-activation of the G2 checkpoint seems to be DNA-PKcs-specific 
as it is not observed after depletion of KU70/80, and is associated with enhanced 
resection at IR-generated DSBs as analyzed by RPA foci formation. However, 
chemical inactivation of DNA-PKcs does not completely replicate the increased level 
of RPA foci observed in DNA-PKcs deficient cells. Nevertheless, this result suggests 
that the DNA-PKcs’ catalytic function may be essential in order to actively regulate 
the process of DNA end resection. 
To identify potential targets of DNA-PKcs in DSB end resection, we applied RNAi 
screening and found that CtIP, MRN complex and DNA2 nuclease/helicase are good 
candidates to be regulated by DNA-PKcs kinase activity.  Subsequent in vitro, as well 
as immunoprecipitation experiments are needed to confirm the interaction of 
DNA-PKcs with the proposed targets. 
Administration of specific ATM and ATR kinase inhibitors as well as inhibitors of their 
downstream targets CHK1 and CHK2 revealed that ATM inactivation is associated 
with less enhanced G2 checkpoint activation and significant decrease of DNA end 
resection following exposure to IR in comparison to elimination of DNA-PKcs activity. 
Interestingly, the data also point to contribution of ATR in the regulation of G2 
checkpoint and DNA end resection through CHK1 not only in DNA-PKcs deficient but 
also in normal cells, suggesting that ATR does not only passively respond to ssDNA 
but may actively regulate the initial steps of these processes. 
Collectively, these results link DNA-PKcs to checkpoint response activation via 
regulation of DNA end resection and imply a cross-talk between the three PIKK 
kinases ATM, ATR and DNA-PKcs. 
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